This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Alzheimer disease, excluding more controls
G6_ALZHEIMER_EXMORE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- G6_AD_WIDE, F5_DEMENTIA, F5_DEMENTIA_U, F5_PSYCH, NEURODIS, MEMLOSS, TRAUMBRAIN_NONCONCUS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G30-G32
- Name in latin
- Morbus Alzheimer
Similar endpoints
↥List of similar endpoints to
Alzheimer disease, excluding more controls
based on the number of shared cases.
Similar with more cases:
- Alzheimer disease
- Degenerative diseases of the nervous system
- Alzheimer disease, including avohilmo
- Other degenerative diseases of the nervous system
- Unspecific neurodegenerative disorder
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 14379 | 6758 | 7621 |
| Unadjusted period prevalence (%) | 2.86 | 2.30 | 3.36 |
| Median age at first event (years) | 80.52 | 80.57 | 80.47 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3330
- Matched controls
- 28983
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G30.0
ICD-10 Finland
Alzheimer disease with early onset
4602.4
323.0
467
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
415.4
323.0
750
20
P70
ICPC
Dementia
227.2
323.0
351
15
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
12.8
323.0
638
525
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
163.6
323.0
398
24
N06DX01
ATC
memantine; oral
2042.5
323.0
1823
17
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
323.0
692
*
N05AH04
ATC
quetiapine; oral
17.6
323.0
728
454
N06DA04
ATC
galantamine; oral
989.2
323.0
401
*
AA1AD
NOMESCO Finland
CT of head and brain
9.0
323.0
1219
1741
TAB00
NOMESCO Finland
Lumbar puncture
38.8
323.0
460
119
A28
ICPC
Limited function/disability NOS
7.8
323.0
1100
1716
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
1204.2
323.0
833
8
N06DA02
ATC
donepezil; oral
1288.6
323.0
1833
27
F03
ICD-10 Finland
Unspecified dementia
121.0
323.0
557
48
SPAT1053
SPAT
Memory test
8.1
323.0
1621
3020
N05AX08
ATC
risperidone; systemic
171.7
323.0
739
48
G30.8
ICD-10 Finland
Other Alzheimer disease
457.3
323.0
496
11
N06DA03
ATC
rivastigmine; oral, transdermal
1355.2
323.0
989
9
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
31.0
323.0
1195
514
G30.1
ICD-10 Finland
Alzheimer disease with late onset
560.6
323.0
1832
63
P20
ICPC
Memory disturbance
24.3
323.0
1794
1327
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
186.9
320.3
347
18
F06.7
ICD-10 Finland
Mild cognitive disorder
54.2
306.1
382
69
R41.3
ICD-10 Finland
Other amnesia
55.0
298.8
372
66
G30
ICD-10 Finland
Alzheimer disease
709.6
291.0
298
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
154.1
277.9
306
19
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
+∞
275.8
275
*
SPAT1216
SPAT
Assessment of functional ability
5.2
267.5
993
2171
SPAT1245
SPAT
Provision of support and information to patient’s family members
16.4
259.7
448
272
G47.3
ICD-10 Finland
Sleep apnoea
18.9
256.5
419
219
XA800
NOMESCO Finland
Neuropsychological investigation
82.2
256.3
301
35
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.9
250.5
810
1489
N03AG01
ATC
valproic acid; systemic, rectal
96.3
246.4
284
28
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
240.2
240
*
SPAT1234
SPAT
Support of social functional capacity
16.8
236.5
403
235
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
236.1
236
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
12.3
232.9
455
367
N06AX11
ATC
mirtazapine; oral
4.0
226.9
1160
3403
R53
ICD-10 Finland
Malaise and fatigue
4.8
215.4
858
1963
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
13.4
212.6
398
290
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
200.7
201
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
21.0
198.7
312
142
N05AH03
ATC
olanzapine; systemic
62.9
198.4
242
36
S06.0
ICD-10 Finland
Concussion
20.5
196.4
311
145
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.5
193.7
808
1913
N05BA04
ATC
oxazepam; oral
3.9
188.8
945
2647
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.6
173.2
573
1041
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.3
172.1
1170
4134
N06AB10
ATC
escitalopram; oral
5.2
166.0
583
1132
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
31.7
165.7
231
68
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
9.8
156.3
341
333
N06AB04
ATC
citalopram; systemic
4.0
150.5
700
1791
R41.0
ICD-10 Finland
Disorientation, unspecified
33.0
150.1
207
58
L28
ICPC
Limited function/disability (L)
3.8
144.2
722
1963
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
17.0
136.1
229
125
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
135.3
136
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
424.7
134.7
141
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
12.3
132.0
255
194
SPAT1254
SPAT
Administration of medicine
3.8
131.5
646
1715
N06AX26
ATC
vortioxetine; oral
19.7
130.9
209
98
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1197.3
129.2
132
*
A04
ICPC
Weakness/tiredness general
4.3
126.3
530
1215
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
274.7
113.4
121
*
F05.9
ICD-10 Finland
Delirium, unspecified
205.2
105.2
114
5
A06AD11
ATC
lactulose; oral
3.5
103.3
565
1610
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
104.5
101.4
116
10
R42
ICD-10 Finland
Dizziness and giddiness
2.8
100.0
810
3020
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
33.4
97.0
133
36
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
451.0
96.6
101
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
21.2
94.6
147
63
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
+∞
93.2
94
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
93.2
94
*
Z2445
NOMESCO Finland
Psychologist
32.1
92.5
128
36
N05BA06
ATC
lorazepam; systemic, sublingual
7.2
91.9
240
309
WYA20
NOMESCO Finland
Home visit
34.2
91.7
125
33
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
90.3
91
*
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
88.3
89
*
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
282.6
88.2
94
*
SPAT1229
SPAT
Assessment of need for aid
4.4
88.2
354
763
N06AX21
ATC
duloxetine; oral
5.3
87.9
293
518
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.4
87.0
287
501
N05AD01
ATC
haloperidol; systemic
14.1
85.5
154
99
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
33.7
84.8
116
31
R56.8
ICD-10 Finland
Other and unspecified convulsions
12.4
84.4
161
118
F29
ICD-10 Finland
Unspecified nonorganic psychosis
201.0
83.0
90
*
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
94.4
82.2
95
9
N06AX16
ATC
venlafaxine; oral
4.7
81.8
302
596
SPAT1301
SPAT
No procedures
2.2
81.6
1232
6206
ACC51
NOMESCO Finland
Release of median nerve
63.4
81.4
99
14
G20
ICD-10 Finland
Parkinson disease
62.5
80.5
98
14
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
80.3
81
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
79.7
822
3449
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.5
79.6
255
429
N05AB03
ATC
perphenazine; systemic, rectal
27.0
79.0
114
38
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
78.3
79
*
U04
ICPC
Incontinence urine
5.4
75.9
248
427
N06AB06
ATC
sertraline; oral
4.7
74.2
277
552
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.8
74.2
543
1862
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
30.8
73.8
103
30
K90
ICPC
Stroke/cerebrovascular accident
46.7
73.6
94
18
SPAT1101
SPAT
Orthostatic test
5.0
73.6
255
469
F05.1
ICD-10 Finland
Delirium superimposed on dementia
+∞
73.3
74
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
10.8
71.9
146
122
R55
ICD-10 Finland
Syncope and collapse
3.1
71.7
442
1351
Z01.9
ICD-10 Finland
Special examination, unspecified
4.2
70.8
292
642
SPAT1172
SPAT
Guidance concerning hydration
11.9
70.7
137
104
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
638.5
69.5
72
*
N03AX14
ATC
levetiracetam; systemic
33.6
68.9
94
25
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.8
68.5
246
470
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
317.7
68.0
72
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
12.5
67.7
128
92
N05AA02
ATC
levomepromazine; systemic
16.1
66.4
113
63
SPAT1304
SPAT
Counselling and guidance related to ageing
3.1
63.9
393
1193
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
584.0
63.6
66
*
N03AF02
ATC
oxcarbazepine; oral
34.1
61.8
84
22
SPAT1246
SPAT
Screening of depression or other psychiatric problem
9.4
61.7
135
130
N02BE01
ATC
paracetamol; systemic, rectal
2.2
60.8
2845
21095
SPAT1360
SPAT
Extensive global examination
3.2
60.4
358
1056
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
547.8
59.6
62
*
W19
ICD-10 Finland
Unspecified fall
3.4
58.9
316
867
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
57.5
565
2265
N03AE01
ATC
clonazepam; systemic
6.2
56.5
163
240
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
55.4
56
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
502.7
54.7
57
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.6
54.2
148
202
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
53.5
459
1705
I95.1
ICD-10 Finland
Orthostatic hypotension
6.3
53.5
151
216
S01.0
ICD-10 Finland
Open wound of scalp
3.6
53.4
266
686
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
52.2
551
8249
N29
ICPC
Neurological sympt/complt other
14.4
52.0
92
57
F00
ICD-10 Finland
Dementia in Alzheimer disease
475.7
51.7
54
*
SPAT1252
SPAT
Overall medication plan or its review
3.1
51.6
311
926
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
51.5
52
*
F22.0
ICD-10 Finland
Delusional disorder
244.0
51.3
55
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
466.7
50.8
53
*
G72.8
ICD-10 Finland
Other specified myopathies
466.7
50.8
53
*
N05AX12
ATC
aripiprazole; systemic
466.7
50.8
53
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
12.0
50.7
97
72
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
457.7
49.8
52
*
R5140
NOMESCO Finland
Monitoring the use of the aid
4.8
49.7
179
342
N03AF01
ATC
carbamazepine; oral, rectal
6.6
49.0
133
180
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
448.7
48.8
51
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
+∞
48.5
49
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
+∞
48.5
49
*
N06AA09
ATC
amitriptyline; systemic
3.1
47.5
291
875
R51.80
ICD-10 Finland
Headache
3.0
47.5
302
930
A29
ICPC
General symptom/complaint other
2.5
47.4
426
1617
SPAT1307
SPAT
Psychosocial counselling and guidance
7.6
47.4
117
138
G31.0
ICD-10 Finland
Circumscribed brain atrophy
153.0
47.2
52
*
N04AA02
ATC
biperiden; systemic
81.0
47.0
55
6
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
46.5
47
*
N05AN01
ATC
lithium; oral
51.3
46.4
58
10
G44.2
ICD-10 Finland
Tension-type headache
3.4
46.1
244
659
F21
ICPC
NA
34.3
45.9
62
16
N05CD07
ATC
temazepam; oral
2.6
45.7
373
1341
C10AA01
ATC
simvastatin; oral
1.7
45.6
1750
11455
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
40.1
45.1
59
13
P29
ICPC
Psychological sympt/compl other
8.0
44.8
107
120
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
44.5
449
1806
B01AC04
ATC
clopidogrel; oral
2.2
44.4
516
2220
N18
ICPC
Paralysis/weakness
19.4
44.3
70
32
S72.0
ICD-10 Finland
Fracture of neck of femur
4.8
44.3
158
299
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
90.1
44.1
51
5
Z02.7
ICD-10 Finland
Issue of medical certificate
3.7
43.6
205
503
F20.9
ICD-10 Finland
Schizophrenia, unspecified
+∞
43.5
44
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
207.2
43.5
47
*
N03AX09
ATC
lamotrigine; oral
23.0
43.4
65
25
F34.1
ICD-10 Finland
Dysthymia
36.0
42.7
57
14
WX780
NOMESCO Finland
Remote monitoring CPAP
138.1
42.3
47
*
N05BA01
ATC
diazepam; systemic, rectal
2.5
42.1
355
1299
N02AA05
ATC
oxycodone; systemic
2.1
42.0
526
2335
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
385.9
41.9
44
*
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
8.4
41.6
96
102
N17
ICPC
Vertigo/dizziness
2.4
41.5
403
1586
N06AB03
ATC
fluoxetine; oral
2.7
41.4
307
1041
T36
ICD-10 Finland
Poisoning by systemic antibiotics
15.9
41.3
70
39
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
40.8
251
755
G04BD12
ATC
mirabegron; oral
2.3
40.7
434
1787
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
40.6
1071
6218
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
40.6
348
1283
N05AH02
ATC
clozapine; systemic
+∞
40.5
41
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.6
40.1
147
286
C03CA01
ATC
furosemide; systemic
1.8
40.1
900
4963
N05CF01
ATC
zopiclone; oral
1.8
39.7
927
5171
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.0
39.7
254
784
S06.3
ICD-10 Finland
Focal brain injury
+∞
39.6
40
*
F0019, G301
ICD-10 Finland
NA
+∞
39.6
40
*
P03
ICPC
Feeling depressed
4.7
39.5
141
267
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
39.2
297
1018
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
39.1
275
902
N30.0
ICD-10 Finland
Acute cystitis
2.2
38.9
440
1860
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
38.7
695
3547
N87
ICPC
Parkinsonism
184.8
38.7
42
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
38.6
626
3076
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
59.1
38.6
47
7
Z75.5
ICD-10 Finland
Holiday relief care
67.6
38.5
46
6
F01.9
ICD-10 Finland
Vascular dementia, unspecified
67.6
38.5
46
6
F10.20
ICD-10 Finland
Alcohol dependence currently independent
96.9
38.4
44
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
15.0
38.2
66
39
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
18.0
37.8
61
30
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
37.6
475
2106
N05AF03
ATC
chlorprothixene; systemic
30.6
37.6
52
15
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
37.6
38
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
37.5
299
1056
K91
ICPC
Cerebrovascular disease
32.2
37.3
51
14
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
36.6
37
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.5
36.5
114
186
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
36.4
387
1589
SPAT1263
SPAT
Sampling
1.6
36.1
1330
8409
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.3
36.1
354
1395
IGY02
NOMESCO Finland
Psychiatric monitoring contact
171.5
35.7
39
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
35.7
229
708
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
35.6
36
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
9.5
35.5
76
71
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
35.5
505
2353
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
11.1
35.5
70
56
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
6.8
35.2
93
122
R11
ICD-10 Finland
Nausea and vomiting
2.8
35.1
242
784
AXX01
SPAT
NA
6.7
34.8
93
124
F05.8
ICD-10 Finland
Other delirium
+∞
34.6
35
*
F009, G309
ICD-10 Finland
NA
+∞
34.6
35
*
SPAT1139
SPAT
Nutrition survey
4.4
34.5
132
269
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.3
34.2
334
1314
F32
ICD-10 Finland
Depressive episode
6.0
34.0
99
148
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
36.0
33.8
45
11
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
36.0
33.8
45
11
SPAT1240
SPAT
Therapeutic discussion
3.3
33.8
181
493
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
33.6
34
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
33.6
490
2300
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.4
33.5
72
68
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
8.1
33.4
78
85
N03AX16
ATC
pregabalin; oral
1.9
33.1
592
2998
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
32.9
763
4207
N06AX03
ATC
mianserin; oral
4.3
32.8
127
262
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
32.6
954
5627
SPAT1167
SPAT
Insertion of urinary catheter
4.0
32.5
138
310
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
296.5
32.1
34
*
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
296.5
32.1
34
*
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
296.5
32.1
34
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
31.9
485
2311
N06AG02
ATC
moclobemide; oral
4.2
31.8
128
274
F10.25
ICD-10 Finland
Alcohol dependence continuous use
81.3
31.8
37
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
31.6
32
*
F0009, G300
ICD-10 Finland
NA
+∞
31.6
32
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
+∞
31.6
32
*
N99
ICPC
Neurological disease other
23.0
31.6
47
18
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
7.6
31.6
77
90
J01EA01
ATC
trimethoprim; systemic
1.7
31.4
739
4086
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.5
31.3
265
965
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
18.4
31.3
50
24
C10AA05
ATC
atorvastatin; oral
1.6
31.1
1398
9184
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
30.7
372
1614
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
+∞
30.6
31
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
30.6
31
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
30.6
31
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
+∞
30.6
31
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
30.5
487
2361
SPAT1050
SPAT
Extensive neurological examination
5.9
30.5
89
134
N05AC02
ATC
thioridazine; oral
32.8
30.3
41
11
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
32.8
30.3
41
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
30.0
1419
9405
SPAT1260
SPAT
Consultation of another employee
1.8
30.0
610
3212
N28
ICPC
Limited function/disability (N)
13.2
29.8
54
36
SPAT1262
SPAT
Handing over of treatment supplies
1.8
29.8
623
3308
E86
ICD-10 Finland
Volume depletion
6.2
29.8
84
121
A10AE04
ATC
insulin glargine; parenteral
2.4
29.8
282
1088
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
29.6
30
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
29.6
30
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
29.6
30
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
+∞
29.6
30
*
N27
ICPC
Fear of neurological disease other
7.0
29.6
76
96
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.8
29.4
130
303
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.7
29.3
135
326
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
274.2
29.2
31
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
27.7
29.1
41
13
N05BE01
ATC
buspirone; oral
7.7
28.9
70
81
F10.09
ICD-10 Finland
Alcohol intoxication UNS
96.6
28.9
33
*
S70.0
ICD-10 Finland
Contusion of hip
4.2
28.8
115
245
J01CA08
ATC
pivmecillinam; oral
1.6
28.7
1059
6591
G45.4
ICD-10 Finland
Transient global amnesia
14.9
28.5
49
29
K59.0
ICD-10 Finland
Constipation
3.0
28.5
177
535
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
28.5
209
701
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.8
28.2
198
648
P76
ICPC
Depressive disorder
5.3
28.2
89
148
WX723
NOMESCO Finland
CPAP therapy
72.5
28.0
33
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
72.5
28.0
33
*
N19
ICPC
Speech disorder
28.6
27.9
39
12
N05AF05
ATC
zuclopenthixol; systemic
+∞
27.7
28
*
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
27.7
28
*
C01DA14
ATC
isosorbide mononitrate; oral
1.9
27.6
479
2387
F32.1
ICD-10 Finland
Moderate depressive episode
10.3
27.6
56
48
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
27.1
152
427
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
26.9
238
889
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.5
26.9
99
195
A02BC03
ATC
lansoprazole; oral
1.6
26.7
841
5009
G40
ICD-10 Finland
Epilepsy
+∞
26.7
27
*
N03AX12
ATC
gabapentin; oral
2.0
26.5
353
1590
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
26.4
186
608
N06AX12
ATC
bupropion; oral
8.4
26.4
60
63
N04BD01
ATC
selegiline; oral
246.6
26.2
28
*
R25.1
ICD-10 Finland
Tremor, unspecified
5.1
26.2
86
150
R06.5
ICD-10 Finland
Mouth breathing
3.2
26.1
146
409
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
25.8
737
4270
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
25.7
26
*
A01
ICPC
Pain general/multiple sites
2.5
25.7
221
812
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
41.4
25.7
33
7
M48.0
ICD-10 Finland
Spinal stenosis
2.0
25.5
374
1748
N05AD03
ATC
melperone; systemic
26.4
25.3
36
12
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
237.4
25.3
27
*
ZXD05
NOMESCO Finland
Urgent procedure
1.6
24.9
813
4874
R35
ICD-10 Finland
Polyuria
2.5
24.8
210
764
T90.5
ICD-10 Finland
Sequelae of intracranial injury
40.1
24.8
32
7
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
+∞
24.7
25
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
+∞
24.7
25
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
10.2
24.6
50
43
R1250
NOMESCO Finland
Evaluation of functional capability
6.0
24.3
69
101
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
24.0
813
4912
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
23.7
24
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
23.7
24
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
+∞
23.7
24
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
23.7
24
*
G45.3
ICD-10 Finland
Amaurosis fugax
43.8
23.6
30
6
G51.0
ICD-10 Finland
Bell palsy
15.3
23.6
40
23
PA7BD
NOMESCO Finland
CT angiography of neck and brain
10.1
23.5
48
42
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
23.3
895
5563
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
219.1
23.3
25
*
N06AX05
ATC
trazodone; oral
7.2
23.3
58
71
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
23.2
356
1688
IGY99
NOMESCO Finland
Other psychiatric treatment contact
78.9
23.2
27
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
113.9
23.2
26
*
Z29
ICPC
Social problem NOS
8.8
23.2
51
51
R33
ICD-10 Finland
Retention of urine
2.1
23.2
269
1141
P99
ICPC
Psychological disorders other
14.1
22.9
40
25
F001, G301
ICD-10 Finland
NA
+∞
22.7
23
*
35399
ICD-8 Finland
Sciatica
+∞
22.7
23
*
188
Kela drug reimbursment
Psychosis requiring demanding treatment
+∞
22.7
23
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
22.7
23
*
N05BA12
ATC
alprazolam; oral
2.3
22.6
232
930
R44.3
ICD-10 Finland
Hallucinations, unspecified
210.1
22.4
24
*
G04BD08
ATC
solifenacin; oral
2.2
22.3
236
961
P28
ICPC
Limited function/disability (P)
76.0
22.3
26
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
109.5
22.2
25
*
ZXY02
NOMESCO Finland
Neuropsychologist
109.5
22.2
25
*
P01
ICPC
Feeling anxious/nervous/tense
3.2
22.1
119
327
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
9.6
22.0
46
42
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.0
22.0
292
1309
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
40.9
21.8
28
6
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
21.7
22
*
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
+∞
21.7
22
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
21.7
22
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
21.7
22
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
+∞
21.7
22
*
H02AB02
ATC
dexamethasone; systemic
0.4
21.6
130
2408
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
15.8
21.6
36
20
R63.4
ICD-10 Finland
Abnormal weight loss
2.9
21.5
134
407
N04BC05
ATC
pramipexole; oral
2.5
21.5
181
659
P15
ICPC
Chronic alcohol abuse
7.9
21.3
50
56
P72
ICPC
Schizophrenia
105.1
21.3
24
*
R32
ICD-10 Finland
Unspecified urinary incontinence
3.6
21.2
98
239
N03AB02
ATC
phenytoin; systemic
17.6
21.2
34
17
M54.5
ICD-10 Finland
Low back pain
1.5
21.0
762
4654
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
20.9
710
4268
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
+∞
20.7
21
*
S06.2
ICD-10 Finland
Diffuse brain injury
+∞
20.7
21
*
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
+∞
20.7
21
*
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
+∞
20.7
21
*
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
+∞
20.7
21
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
20.7
453
2419
I63.8
ICD-10 Finland
Other cerebral infarction
45.5
20.7
26
5
B01AA03
ATC
warfarin; systemic
1.6
20.7
597
3443
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
20.6
832
5208
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
54.7
20.5
25
*
SPAT1243
SPAT
Psychiatric/psychological examination
11.4
20.4
39
30
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
100.7
20.3
23
*
D12
ICPC
Constipation
3.0
20.3
122
362
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.7
20.2
90
213
N06AA12
ATC
doxepin; systemic
3.0
20.2
125
377
B01AC07
ATC
dipyridamole; systemic
3.7
20.2
91
218
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
20.0
144
478
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
+∞
19.8
20
*
N05AL01
ATC
sulpiride; systemic
8.8
19.7
43
43
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
183.7
19.4
21
*
M79.6
ICD-10 Finland
Pain in limb
1.5
19.4
930
6026
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
32.6
19.4
26
7
G04BD04
ATC
oxybutynin; oral, transdermal
2.4
19.4
172
642
N30.9
ICD-10 Finland
Cystitis, unspecified
2.6
19.3
145
496
R51
ICD-10 Finland
Headache
3.4
19.3
98
259
F01.2
ICD-10 Finland
Subcortical vascular dementia
36.5
19.1
25
6
A10BB01
ATC
glibenclamide; oral
2.9
19.1
120
368
SPAT1251
SPAT
Organisation of medication
3.2
19.0
103
285
Z2446
NOMESCO Finland
Social worker
2.7
19.0
136
452
G47.9
ICD-10 Finland
Sleep disorder, unspecified
7.6
18.9
45
52
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
17.5
18.8
30
15
F0014, G301
ICD-10 Finland
NA
+∞
18.8
19
*
F0011, G301
ICD-10 Finland
NA
+∞
18.8
19
*
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
18.8
19
*
AA400
NOMESCO Finland
Electroconvulsive therapy
+∞
18.8
19
*
J01MA02
ATC
ciprofloxacin; systemic
1.4
18.7
1145
7774
R4120
NOMESCO Finland
Occupational therapy
2.7
18.7
137
460
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
174.9
18.5
20
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
174.9
18.5
20
*
N05AA01
ATC
chlorpromazine; systemic, rectal
91.9
18.4
21
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
91.9
18.4
21
*
130
Kela drug reimbursment
Malignant tumour
0.4
18.4
100
1924
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
15.1
18.4
31
18
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
18.3
242
1083
R2110
NOMESCO Finland
Giving the first information
2.2
18.2
188
755
Z51.88
ICD-10 Finland
Other specified medical care
3.5
18.2
89
228
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
10.5
18.2
36
30
N06AB05
ATC
paroxetine; oral
2.9
18.2
115
354
N04BC04
ATC
ropinirole; oral
21.5
18.1
27
11
SPAT1281
SPAT
Other administrative function
2.0
18.0
244
1102
P06
ICPC
Sleep disturbance
2.4
18.0
166
632
Z28
ICPC
Limited function/disability (Z)
27.4
17.9
25
8
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
8.0
17.8
41
45
N01
ICPC
Headache
2.3
17.8
170
659
G35
ICD-10 Finland
Multiple sclerosis
+∞
17.8
18
*
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
+∞
17.8
18
*
N03AX18
ATC
lacosamide; systemic
+∞
17.8
18
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
48.1
17.7
22
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
17.7
724
4521
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
17.7
247
1129
A01AB09
ATC
miconazole; local oral
2.0
17.6
251
1156
S00.0
ICD-10 Finland
Superficial injury of scalp
4.5
17.6
64
126
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
7.8
17.6
41
46
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
17.3
239
1088
R60.0
ICD-10 Finland
Localized oedema
1.8
17.3
315
1582
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.5
17.3
52
83
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.9
17.3
73
166
R4130
NOMESCO Finland
Speech therapy
5.5
17.2
52
84
G56.2
ICD-10 Finland
Lesion of ulnar nerve
9.3
17.1
36
34
P05
ICPC
Senility, feeling/behaving old
26.3
17.0
24
8
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
26.3
17.0
24
8
M03BX01
ATC
baclofen; systemic
8.8
17.0
37
37
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.4
17.0
84
218
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
16.9
2014
15259
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
45.9
16.8
21
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
+∞
16.8
17
*
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
16.8
17
*
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
+∞
16.8
17
*
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
+∞
16.8
17
*
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
+∞
16.8
17
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
16.8
17
*
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
+∞
16.8
17
*
F31.8
ICD-10 Finland
Other bipolar affective disorders
+∞
16.8
17
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
16.8
17
*
U13
ICPC
Bladder symptom/complaint other
2.8
16.7
108
338
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.1
16.7
46
66
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
16.6
792
5095
A10AE05
ATC
insulin detemir; parenteral
2.5
16.6
140
508
SPAT1279
SPAT
Preparation of immediate hospitalisation
8.8
16.6
36
36
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
157.3
16.5
18
*
AAF00
NOMESCO Finland
Ventriculostomy
157.3
16.5
18
*
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
157.3
16.5
18
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
16.4
66
144
ZXA00
NOMESCO Finland
Right side
1.4
16.4
845
5523
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
17.5
16.4
26
13
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
16.3
308
1566
A02BA02
ATC
ranitidine; systemic
1.6
16.3
532
3150
SPAT1125
SPAT
Stoma care and guidance
4.1
16.1
64
138
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
16.1
283
1404
SPAT1285
SPAT
Provision of consultation response
2.2
16.1
176
729
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.3
16.1
60
122
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.3
16.0
153
594
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
43.7
15.9
20
*
J01DA01
ATC
[U] cefalexin; systemic
1.4
15.9
1648
12149
A04AA02
ATC
granisetron; systemic, transdermal
0.4
15.9
63
1363
ZY000
NOMESCO Finland
Hospital inpatient
27.5
15.9
22
7
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
+∞
15.8
16
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
+∞
15.8
16
*
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
+∞
15.8
16
*
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
+∞
15.8
16
*
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
+∞
15.8
16
*
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
+∞
15.8
16
*
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
+∞
15.8
16
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
15.8
16
*
XF606
NOMESCO Finland
Ortostatic test
9.3
15.8
33
31
A05
ICPC
Feeling ill
2.7
15.8
113
377
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
55.3
15.7
19
*
XA400
NOMESCO Finland
EEG
22.4
15.7
23
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
15.6
803
5235
J01DB01
ATC
cefalexin; oral
1.4
15.6
2375
18602
R1250
SPAT
NA
9.7
15.6
32
29
XA420
NOMESCO Finland
Extensive sleep examination
19.1
15.6
24
11
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
15.6
752
4844
E0000UV
ATC
NA
1.4
15.6
1046
7166
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
15.5
1087
7499
K08.3
ICD-10 Finland
Retained dental root
2.0
15.5
198
875
R13
ICD-10 Finland
Dysphagia
2.2
15.4
159
639
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.8
15.4
66
153
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.3
15.2
78
209
N06AA06
ATC
trimipramine; systemic
4.3
15.2
57
117
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.9
15.1
223
1041
Z3226
NOMESCO Finland
Physiotherapist
1.6
15.1
479
2814
WX722
NOMESCO Finland
PEEP
3.8
15.0
65
152
SPAT1284
SPAT
Extensive health certificate
3.3
15.0
77
207
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
14.9
35
954
G43.9
ICD-10 Finland
Migraine, unspecified
7.3
14.9
36
43
81
HP
Angiography of the heart and coronary arteries
2.0
14.9
200
903
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.8
14.8
95
296
R47.0
ICD-10 Finland
Dysphasia and aphasia
21.4
14.8
22
9
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.6
14.8
110
374
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
+∞
14.8
15
*
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
+∞
14.8
15
*
N04BD02
ATC
rasagiline; oral
+∞
14.8
15
*
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
+∞
14.8
15
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
14.8
15
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
+∞
14.8
15
*
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
+∞
14.8
15
*
F06.0
ICD-10 Finland
Organic hallucinosis
+∞
14.8
15
*
29599
ICD-8 Finland
Schizophrenia, Unspecified type
+∞
14.8
15
*
T08
ICPC
Weight loss
3.9
14.6
61
138
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
139.7
14.6
16
*
F33.8
ICD-10 Finland
Other recurrent depressive disorders
139.7
14.6
16
*
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
139.7
14.6
16
*
AA1AA
NOMESCO Finland
Head X-ray examination
5.9
14.6
41
61
A10AA02
ATC
NA
3.7
14.5
64
152
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
14.5
213
994
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
4.5
14.5
52
102
G50.0
ICD-10 Finland
Trigeminal neuralgia
9.4
14.4
30
28
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.3
14.4
142
561
F10.24
ICD-10 Finland
Alcohol depence active use
19.2
14.4
22
10
G04BD07
ATC
tolterodine; oral
2.2
14.3
150
610
SPAT1138
SPAT
Guidance concerning bowel function
4.9
14.3
47
84
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
14.3
1146
8060
Z73.6
ICD-10 Finland
Limitation of activities due to disability
6.0
14.3
40
59
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.6
14.3
42
66
WX212
NOMESCO Finland
Femoral plexus blockade
3.6
14.3
65
159
A27
ICPC
Fear of other disease NOS
2.3
14.3
141
557
W10
ICD-10 Finland
Fall on and from stairs and steps
2.4
14.1
122
452
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
14.0
449
2637
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.5
14.0
66
166
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
20.4
14.0
21
9
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
15.5
13.9
23
13
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
13.8
14
*
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
13.8
14
*
G40.10
ICD-10 Finland
Simple partial seizures
+∞
13.8
14
*
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
+∞
13.8
14
*
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
+∞
13.8
14
*
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
+∞
13.8
14
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
13.8
14
*
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
+∞
13.8
14
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
13.8
14
*
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
+∞
13.8
14
*
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
+∞
13.8
14
*
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.8
13.7
227
1105
A10BA02
ATC
metformin; oral
1.4
13.6
831
5570
S22.3
ICD-10 Finland
Fracture of rib
2.1
13.6
160
682
N05AF01
ATC
flupentixol; systemic
5.4
13.6
41
67
SPAT1104
SPAT
Monitoring of emergency patient
1.9
13.5
191
877
R47.1
ICD-10 Finland
Dysarthria and anarthria
16.0
13.5
22
12
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
13.5
1129
7973
A10AA01
ATC
NA
4.3
13.5
50
102
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.5
13.5
108
384
SPAT1244
SPAT
Occupational therapy
7.1
13.4
33
41
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
13.4
578
3628
C07AB02
ATC
metoprolol; systemic
1.4
13.3
617
3926
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.7
13.3
281
1478
H53.1
ICD-10 Finland
Subjective visual disturbances
2.1
13.3
145
601
SPAT1310
SPAT
Counselling related to known health issue
1.4
13.3
964
6651
S72.1
ICD-10 Finland
Pertrochanteric fracture
3.8
13.2
56
129
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
7.2
13.2
32
39
I95.9
ICD-10 Finland
Hypotension, unspecified
5.1
13.1
41
70
N05CD02
ATC
nitrazepam; oral
4.3
13.1
49
101
S97
ICPC
Chronic ulcer skin
2.1
12.9
144
602
C07AB07
ATC
bisoprolol; oral
1.3
12.9
1494
11062
ZXD35
NOMESCO Finland
Usual procedure
2.7
12.9
87
280
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
+∞
12.8
13
*
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
+∞
12.8
13
*
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
+∞
12.8
13
*
F61.0
ICD-10 Finland
Mixed personality disorders
+∞
12.8
13
*
N88
ICPC
Epilepsy
+∞
12.8
13
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
12.8
13
*
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
+∞
12.8
13
*
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
+∞
12.8
13
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
+∞
12.8
13
*
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
+∞
12.8
13
*
34609
ICD-8 Finland
Migraine, Unspecified
+∞
12.8
13
*
3074A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]
+∞
12.8
13
*
SPAT1094
SPAT
Continuous Positive Airway Pressure
65.6
12.8
15
*
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
12.7
193
912
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.1
12.7
49
104
A02BC01
ATC
omeprazole; systemic
1.4
12.7
731
4842
Z60.8
ICD-10 Finland
Other problems related to social environment
122.2
12.7
14
*
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
122.2
12.7
14
*
AA5PD
NOMESCO Finland
CT examination of brain pefusion
122.2
12.7
14
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
29.7
12.6
17
5
F80.1
ICD-10 Finland
Expressive language disorder
29.7
12.6
17
5
N05BA02
ATC
chlordiazepoxide; systemic
4.3
12.6
47
97
XG466
NOMESCO Finland
Sleep oxymetry
4.3
12.6
46
93
E87.6
ICD-10 Finland
Hypokalaemia
2.7
12.5
86
281
R60.9
ICD-10 Finland
Oedema, unspecified
2.2
12.5
132
539
UKC02
NOMESCO Finland
Cystoscopy
1.5
12.5
502
3099
R07.3
ICD-10 Finland
Other chest pain
1.8
12.5
231
1168
D11
ICPC
Diarrhoea
1.8
12.5
215
1062
A02BC05
ATC
esomeprazole; systemic
1.3
12.5
1072
7584
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.9
12.5
77
236
N07BB01
ATC
disulfiram; oral
3.6
12.4
56
137
F43.29
ICD-10 Finland
Adaptation disorder UNS
14.1
12.4
21
13
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.1
12.3
70
202
I63
ICD-10 Finland
Cerebral infarction
34.9
12.3
16
*
A69
ICPC
General and Unspecified, Other reason for encounter NEC
3.0
12.3
70
203
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
12.3
91
311
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
12.2
1009
7086
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.7
12.2
54
130
S28
ICPC
Limited function/disability (S)
7.7
12.1
28
32
C09AA05
ATC
ramipril; oral
1.4
12.1
789
5333
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
2.3
12.1
117
461
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
12.0
218
1094
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.8
12.0
79
252
AA1AD
SPAT
NA
13.1
12.0
21
14
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
12.0
217
1088
G04BD09
ATC
trospium; oral
2.7
11.9
82
268
C08CA01
ATC
amlodipine; oral
1.3
11.9
1150
8264
F51.0
ICD-10 Finland
Nonorganic insomnia
1.8
11.9
204
1006
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.7
11.9
51
120
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
+∞
11.8
12
*
IGP01
NOMESCO Finland
Psychiatric family contact
+∞
11.8
12
*
29530
ICD-8 Finland
Schizophrenia, Paranoid type
+∞
11.8
12
*
S06.9
ICD-10 Finland
Intracranial injury, unspecified
+∞
11.8
12
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
11.8
12
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
11.8
12
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
11.8
12
*
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
+∞
11.8
12
*
F20.5
ICD-10 Finland
Residual schizophrenia
+∞
11.8
12
*
S01
ICD-10 Finland
Open wound of head
4.8
11.8
39
71
N06AA04
ATC
clomipramine; systemic
4.8
11.8
39
71
205
Kela drug reimbursment
Chronic hypertension
1.3
11.8
893
6183
F32.0
ICD-10 Finland
Mild depressive episode
4.6
11.8
41
79
G25.0
ICD-10 Finland
Essential tremor
3.5
11.8
54
134
A11
ICPC
Chest pain NOS
1.7
11.8
228
1169
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.4
11.8
38
896
F45.0
ICD-10 Finland
Somatization disorder
113.4
11.7
13
*
F31
ICD-10 Finland
Bipolar affective disorder
113.4
11.7
13
*
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
113.4
11.7
13
*
F01
ICD-10 Finland
Vascular dementia
27.9
11.7
16
5
K59.1
ICD-10 Finland
Functional diarrhoea
2.1
11.7
128
530
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
11.7
278
1513
AA1CG
SPAT
NA
6.9
11.7
29
37
G04CA02
ATC
tamsulosin; oral
1.4
11.7
716
4788
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
11.6
1257
9169
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.7
11.6
268
1447
ZY010
NOMESCO Finland
Hospital outpatient
3.0
11.6
67
197
Y94.0
ICD-10 Finland
Accident at home
3.5
11.6
54
136
R44.1
ICD-10 Finland
Visual hallucinations
13.4
11.6
20
13
KMAK
NOMESCO Finland
NA
1.3
11.5
1223
8898
W06
ICD-10 Finland
Fall involving bed
8.4
11.5
25
26
E66.8
ICD-10 Finland
Other obesity
3.1
11.4
63
180
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
7.4
11.4
27
32
A02BC02
ATC
pantoprazole; systemic
1.3
11.4
1848
14227
C07AA05
ATC
propranolol; systemic
1.5
11.4
371
2185
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
4.3
11.4
42
86
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.3
11.3
28
741
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
11.3
156
713
R5110
SPAT
NA
2.6
11.3
82
278
L01BC06
ATC
capecitabine; oral
0.4
11.3
36
851
A46
ICD-10 Finland
Erysipelas
1.5
11.1
371
2196
N06AA10
ATC
nortriptyline; systemic
4.5
11.1
39
76
UJF32
NOMESCO Finland
Coloscopy
1.4
11.1
752
5102
ACC53
NOMESCO Finland
Release of ulnar nerve
40.7
11.1
14
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.0
11.1
65
194
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
3.8
11.0
46
106
S01.8
ICD-10 Finland
Open wound of other parts of head
4.3
11.0
40
81
EBA30
NOMESCO Finland
Excision of root of tooth
2.0
10.9
147
666
T05
ICPC
Feeding problem of adult
9.6
10.9
22
20
N03AX11
ATC
topiramate; oral
11.7
10.9
20
15
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
56.7
10.9
13
*
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
+∞
10.9
11
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
10.9
11
*
LAITO
NOMESCO Finland
NA
+∞
10.9
11
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
10.9
11
*
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
10.9
11
*
193
Kela drug reimbursment
Rasagiline
+∞
10.9
11
*
F0004, G300
ICD-10 Finland
NA
+∞
10.9
11
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
+∞
10.9
11
*
29570
ICD-8 Finland
Schizophrenia, Schizo-affective type
+∞
10.9
11
*
30088
ICD-8 Finland
Neuroses, Other
+∞
10.9
11
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.0
10.8
62
182
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
104.7
10.8
12
*
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
104.7
10.8
12
*
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
104.7
10.8
12
*
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
14.3
10.7
18
11
R52.9
ICD-10 Finland
Pain, unspecified
1.8
10.7
194
975
L75
ICPC
Fracture: femur
3.9
10.7
43
96
359
Kela drug reimbursment
Mirabegroni
6.3
10.7
28
39
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
10.9
10.6
20
16
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
10.6
933
6590
SPAT1127
SPAT
Enema
5.9
10.5
29
43
G04BD10
ATC
darifenacin; oral
5.4
10.5
31
50
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
30.6
10.5
14
*
H53.4
ICD-10 Finland
Visual field defects
3.8
10.5
44
102
H04AA01
ATC
glucagon; nasal, parenteral
4.2
10.5
39
81
A10BB12
ATC
glimepiride; oral
1.8
10.5
197
1001
P27
ICPC
Fear of mental disorder
11.9
10.5
19
14
N80
ICPC
Head injury other
3.9
10.4
42
94
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
10.4
198
1011
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
13.1
10.4
18
12
G45
ICD-10 Finland
Transient cerebral ischaemic attacks and related syndromes
13.1
10.4
18
12
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.3
10.4
51
135
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
21.8
10.3
15
6
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.5
10.3
24
28
E000001
ATC
NA
1.4
10.3
469
2965
SPAT1236
SPAT
Informing family of child’s disability
2.5
10.3
82
293
S22
ICPC
Nail symptom/complaint
1.8
10.3
167
811
XA402
NOMESCO Finland
ENMG
3.8
10.2
43
100
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
10.2
616
4094
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.2
10.2
53
146
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
10.2
381
2312
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.3
10.2
98
384
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.7
10.1
229
1230
R1260
NOMESCO Finland
Evaluation of communicative skills
4.3
10.1
37
76
D21
ICPC
Swallowing problem
4.3
10.1
37
76
A99
ICPC
Disease/condition unspecnature/site
1.7
10.1
219
1163
C10AA03
ATC
pravastatin; oral
1.7
10.1
230
1237
M02AA07
ATC
piroxicam; topical
1.3
10.1
1034
7451
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
10.0
643
4315
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
12.1
10.0
18
13
S20.2
ICD-10 Finland
Contusion of thorax
2.2
10.0
103
419
T90
ICPC
Diabetes non-insulin dependent
1.4
10.0
695
4729
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
24.4
10.0
14
5
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
52.3
10.0
12
*
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
4.3
10.0
36
73
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.3
9.9
49
130
Z51.5
ICD-10 Finland
Palliative care
1.7
9.9
214
1132
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
9.9
160
776
F0029, G308
ICD-10 Finland
NA
+∞
9.9
10
*
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
+∞
9.9
10
*
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
+∞
9.9
10
*
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
+∞
9.9
10
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
9.9
10
*
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
10.4
9.9
19
16
N05CF02
ATC
zolpidem; oral
1.5
9.9
360
2172
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.5
9.8
76
267
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
9.8
93
362
J01FA06
ATC
roxithromycin; oral
1.3
9.8
1015
7315
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
95.9
9.8
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.8
1062
7702
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
3.4
9.8
46
118
AA1XD
NOMESCO Finland
Other special CT of head and brain
11.2
9.7
18
14
Z11
ICPC
Compliance/being ill problem
11.2
9.7
18
14
A78
ICPC
Infectious disease other/NOS
3.9
9.7
39
88
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
9.6
302
1762
I50.0
ICD-10 Finland
Congestive heart failure
1.8
9.6
152
731
R50.9
ICD-10 Finland
Fever, unspecified
1.5
9.6
322
1909
N02AC04
ATC
dextropropoxyphene; oral
2.3
9.6
90
351
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
3.0
9.6
53
153
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.4
9.6
47
936
G54.0
ICD-10 Finland
Brachial plexus disorders
12.4
9.6
17
12
K03.66
ICD-10 Finland
Tooth plaque
1.8
9.6
157
764
J01MA06
ATC
norfloxacin; oral
1.5
9.5
342
2060
A04AA55
ATC
palonosetron, combinations; systemic
0.2
9.5
10
416
F39
ICD-10 Finland
Unspecified mood [affective] disorder
20.4
9.5
14
6
WX892
NOMESCO Finland
Monitored bed care
1.7
9.5
190
987
D17
ICPC
Incontinence of bowel
4.8
9.5
31
57
N06AB08
ATC
fluvoxamine; oral
2.9
9.5
55
164
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
9.4
67
225
A03FA02
ATC
cisapride; oral, rectal
1.7
9.4
188
975
F41.09
ICD-10 Finland
UNS Panic Syndrome
5.8
9.4
26
39
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
5.8
9.4
26
39
A02BX02
ATC
sucralfate; oral
2.1
9.4
101
419
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
9.4
163
808
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
9.4
543
3580
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
34.9
9.3
12
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.3
9.3
24
623
N06AX22
ATC
agomelatine; oral
6.7
9.3
23
30
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
5.7
9.3
26
40
C10AA04
ATC
fluvastatin; oral
1.5
9.2
288
1682
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
12.7
9.2
16
11
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
9.1
195
1031
D01AC02
ATC
miconazole; topical
1.7
9.1
198
1050
SPAT1241
SPAT
Extensive assessment of psychosocial situation
22.7
9.1
13
5
S09.9
ICD-10 Finland
Unspecified injury of head
4.9
9.1
29
52
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
17.5
9.1
14
7
DJA10
NOMESCO Finland
Biopsy of septum of nose
17.5
9.1
14
7
A10BH01
ATC
sitagliptin; oral
1.6
9.1
269
1551
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.6
9.0
65
221
A02BA04
ATC
nizatidine; systemic
1.7
9.0
189
994
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.0
9.0
107
463
U28
ICPC
Limited function/disability (U)
3.9
9.0
36
81
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
9.0
651
4450
S00.8
ICD-10 Finland
Superficial injury of other parts of head
3.7
9.0
38
90
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
9.0
295
3581
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
8.9
188
990
K92.0
ICD-10 Finland
Haematemesis
2.8
8.9
56
175
SPAT1014
SPAT
Treatment of eyes
2.9
8.9
52
156
R05FB02
ATC
cough suppressants and expectorants
1.3
8.9
1034
7548
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.5
8.9
286
1678
2505B
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI I]
+∞
8.9
9
*
F0024, G308
ICD-10 Finland
NA
+∞
8.9
9
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
8.9
9
*
I67.4
ICD-10 Finland
Hypertensive encephalopathy
+∞
8.9
9
*
29580
ICD-8 Finland
Schizophrenia, Other
+∞
8.9
9
*
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
+∞
8.9
9
*
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
+∞
8.9
9
*
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
+∞
8.9
9
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
8.9
9
*
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
8.9
9
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
8.9
9
*
30180
ICD-8 Finland
Personality disorders, Immatura
+∞
8.9
9
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
8.9
9
*
RT250
NOMESCO Finland
NA
+∞
8.9
9
*
F20.0
ICD-10 Finland
Paranoid schizophrenia
+∞
8.9
9
*
F00.12
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
+∞
8.9
9
*
2953E
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]
+∞
8.9
9
*
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
+∞
8.9
9
*
29999
ICD-8 Finland
Unspecified psychosis
+∞
8.9
9
*
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
+∞
8.9
9
*
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
+∞
8.9
9
*
R40.2
ICD-10 Finland
Coma, unspecified
6.3
8.9
23
32
RS222
NOMESCO Finland
NA
5.1
8.9
27
46
RD211
NOMESCO Finland
NA
0.4
8.9
27
650
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
87.2
8.9
10
*
G62.8
ICD-10 Finland
Other specified polyneuropathies
87.2
8.9
10
*
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
87.2
8.9
10
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
87.2
8.9
10
*
N05CD08
ATC
midazolam; nasal, systemic
2.6
8.8
64
219
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.9
8.8
136
650
S22.4
ICD-10 Finland
Multiple fractures of ribs
2.9
8.8
51
152
PJA12
NOMESCO Finland
Sentinel node biopsy
0.6
8.8
108
1621
R25.2
ICD-10 Finland
Cramp and spasm
2.8
8.8
55
171
R06.0
ICD-10 Finland
Dyspnoea
1.3
8.8
597
4039
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
8.8
272
1585
A03CA02
ATC
clidinium and psycholeptics; oral
1.8
8.8
154
768
R45.1
ICD-10 Finland
Restlessness and agitation
26.2
8.8
12
*
Z50.1
ICD-10 Finland
Other physical therapy
1.8
8.7
137
659
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
2.2
8.7
88
354
A10BX01
ATC
guar gum; systemic
2.0
8.7
111
495
L17
ICPC
Foot/toe symptom/complaint
1.3
8.7
682
4716
E16.19
ICD-10 Finland
Other specified hypoglycaemia
18.9
8.7
13
6
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
8.6
104
453
-2
ICPC
NA
8.7
8.6
18
18
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.8
8.6
54
169
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.0
8.6
49
144
D07AA02
ATC
hydrocortisone; topical
1.5
8.6
262
1518
M01AX17
ATC
nimesulide; oral
1.3
8.6
684
4738
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
8.6
301
1800
HMAK
NOMESCO Finland
NA
0.6
8.5
117
1703
P74
ICPC
Anxiety disorder/anxiety state
3.9
8.5
34
77
XF404
NOMESCO Finland
Ambulatory ECG
1.5
8.5
255
1477
-
ICD-10 Finland
NA
2.5
8.4
65
231
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
8.4
1028
7542
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
8.4
457
2980
-1
ICPC
NA
2.7
8.4
54
173
WX402
NOMESCO Finland
General anaesthesia
0.7
8.4
235
2939
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
8.4
95
403
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
8.3
8.4
18
19
H02AA02
ATC
fludrocortisone; oral
7.0
8.4
20
25
A08
ICPC
Swelling
1.9
8.3
112
509
Z03
ICPC
Housing/neighbourhood problem
13.6
8.3
14
9
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
8.3
410
2627
G44.0
ICD-10 Finland
Cluster headache syndrome
20.9
8.3
12
5
R44.0
ICD-10 Finland
Auditory hallucinations
20.9
8.3
12
5
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
16.2
8.2
13
7
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
16.2
8.2
13
7
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
8.2
1070
7900
K07
ICPC
Swollen ankles/oedema
1.9
8.2
119
555
Z72.1
ICD-10 Finland
Alcohol use
6.3
8.2
21
29
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
8.2
147
739
N06AX18
ATC
reboxetine; oral
5.6
8.2
23
36
M01AH02
ATC
rofecoxib; oral
1.4
8.2
351
2190
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
8.1
530
3560
U05
ICPC
Urination problems other
1.8
8.1
128
619
SPAT1312
SPAT
General health counselling
1.3
8.1
893
6463
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.5
8.1
278
1659
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
8.1
863
6220
R30.0
ICD-10 Finland
Dysuria
2.2
8.0
82
335
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
8.0
263
1554
PA6AD
NOMESCO Finland
CT of neck arteries
5.4
8.0
23
37
SPAT1111
SPAT
Planning of analgesia
3.8
8.0
33
77
AN1
HP
Coronary angiography
1.4
7.9
351
2203
SPF30
NOMESCO Finland
Soling for prothesis
2.4
7.9
65
239
N05AB01
ATC
dixyrazine; systemic
6.9
7.9
19
24
F22.8
ICD-10 Finland
Other persistent delusional disorders
78.5
7.9
9
*
N05BA09
ATC
clobazam; oral
78.5
7.9
9
*
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
78.5
7.9
9
*
IGV01
NOMESCO Finland
Psychiatric network contact
78.5
7.9
9
*
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
78.5
7.9
9
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.6
7.9
98
1466
4309X
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]
+∞
7.9
8
*
43599
ICD-8 Finland
Transient cerebral ischaemia, Without mention of hypertension
+∞
7.9
8
*
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
+∞
7.9
8
*
G25.1
ICD-10 Finland
Drug-induced tremor
+∞
7.9
8
*
35701
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Nervi mediani
+∞
7.9
8
*
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
+∞
7.9
8
*
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
+∞
7.9
8
*
F0021, G308
ICD-10 Finland
NA
+∞
7.9
8
*
S06.8
ICD-10 Finland
Other intracranial injuries
+∞
7.9
8
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
7.9
8
*
30680
ICD-8 Finland
Special symptoms not elsewhere classified, Cephalalgia
+∞
7.9
8
*
P98
ICPC
Psychosis NOS/other
+∞
7.9
8
*
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
+∞
7.9
8
*
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
+∞
7.9
8
*
F0024, G301
ICD-10 Finland
NA
+∞
7.9
8
*
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
7.9
8
*
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
+∞
7.9
8
*
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
+∞
7.9
8
*
F002, G308
ICD-10 Finland
NA
+∞
7.9
8
*
F0023, G308
ICD-10 Finland
NA
+∞
7.9
8
*
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
+∞
7.9
8
*
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
+∞
7.9
8
*
43090
ICD-8 Finland
Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata
+∞
7.9
8
*
I62.1
ICD-10 Finland
Nontraumatic extradural haemorrhage
+∞
7.9
8
*
F20
ICD-10 Finland
Schizophrenia
+∞
7.9
8
*
ZXY03
NOMESCO Finland
Occupational therapist
+∞
7.9
8
*
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
+∞
7.9
8
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
+∞
7.9
8
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.7
7.9
51
165
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
17.4
7.8
12
6
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
7.8
303
1851
C10AC01
ATC
colestyramine; oral
2.3
7.8
67
253
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.5
7.7
26
50
A23
ICPC
Risk factor NOS
1.9
7.7
115
544
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
3.0
7.7
42
122
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
7.7
88
376
X58
ICD-10 Finland
Exposure to other specified factors
1.5
7.7
256
1515
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
7.7
222
1273
A10BH05
ATC
linagliptin; oral
1.8
7.7
135
676
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.6
7.6
54
184
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.0
7.6
99
447
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
7.6
657
4594
WZC30
NOMESCO Finland
Teaching
0.7
7.6
225
2788
C03AA03
ATC
hydrochlorothiazide; oral
1.5
7.6
271
1629
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
2.1
7.6
87
371
G50.1
ICD-10 Finland
Atypical facial pain
5.3
7.6
22
36
ZXA05
NOMESCO Finland
Left side
1.3
7.5
741
5272
A86
ICD-10 Finland
Unspecified viral encephalitis
9.4
7.5
15
14
A41.9
ICD-10 Finland
Sepsis, unspecified
2.1
7.5
82
343
Z08
ICPC
Social welfare problem
6.8
7.5
18
23
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.7
7.5
31
73
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.2
7.5
73
293
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
4.4
7.5
26
52
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.4
7.4
59
214
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
7.4
170
918
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
0.5
7.4
49
881
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
7.4
111
528
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
7.4
303
1873
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.2
7.4
74
299
M01AB55
ATC
diclofenac, combinations; oral
1.6
7.4
179
981
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
7.4
173
943
RS230
NOMESCO Finland
NA
10.2
7.4
14
12
SPAT1081
SPAT
Cardiorespiratory global assessment
1.6
7.4
179
984
R06AE07
ATC
cetirizine; oral
1.2
7.3
998
7387
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.4
7.3
34
88
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.3
1301
9928
A13
ICPC
Concern/fear medical treatment
2.7
7.3
47
152
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.1
7.3
81
345
R52.2
ICD-10 Finland
Other chronic pain
2.4
7.3
57
205
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.5
7.2
282
1727
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.6
7.2
20
31
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.3
7.2
34
89
N04BC09
ATC
rotigotine; transdermal
39.2
7.2
9
*
G56.4
ICD-10 Finland
Causalgia
39.2
7.2
9
*
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.9
7.2
97
442
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
11.3
7.2
13
10
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
0.5
7.2
57
964
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.3
7.2
62
233
D10
ICPC
Vomiting
2.4
7.2
59
216
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.9
7.2
101
470
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
7.2
95
433
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.1
312
1954
115
Kela drug reimbursment
Breast cancer
0.6
7.1
127
1742
K01
ICPC
Heart pain
2.9
7.1
41
123
S20
ICPC
Corn/callosity
2.4
7.1
56
202
C08CA05
ATC
nifedipine; systemic
1.7
7.1
147
773
4471
FHL
Pharyngoplasty
9.4
7.1
14
13
U02
ICPC
Urinary frequency/urgency
1.4
7.1
359
2309
R03BB04
ATC
tiotropium bromide; inhalant
1.5
7.1
220
1286
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
2.1
7.1
74
305
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
3.3
7.1
34
91
SPAT1277
SPAT
Instruction concerning legal protection and patient’s rights
21.8
7.0
10
*
R54
ICD-10 Finland
Senility
16.0
7.0
11
6
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
3.1
7.0
37
106
NHQ40
NOMESCO Finland
Amputation of toe
3.1
7.0
37
106
H3603, E103
ICD-10 Finland
NA
5.7
7.0
19
29
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
69.8
7.0
8
*
G93.0
ICD-10 Finland
Cerebral cysts
69.8
7.0
8
*
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
69.8
7.0
8
*
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
69.8
7.0
8
*
79301
ICD-8 Finland
Observation, without need for further medical care, Observatio post tentationem suicidii
69.8
7.0
8
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
7.0
1036
7738
SPAT1042
SPAT
Guidance concerning balance maintenance
5.3
6.9
20
33
F0012, G301
ICD-10 Finland
NA
+∞
6.9
7
*
AAD12
NOMESCO Finland
Drainage of subdural fluid
+∞
6.9
7
*
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
+∞
6.9
7
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
+∞
6.9
7
*
2956C
ICD-9 Finland
Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]
+∞
6.9
7
*
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
6.9
7
*
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
+∞
6.9
7
*
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
+∞
6.9
7
*
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
6.9
7
*
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
+∞
6.9
7
*
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
6.9
7
*
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
6.9
7
*
F20.8
ICD-10 Finland
Other schizophrenia
+∞
6.9
7
*
F000, G300
ICD-10 Finland
NA
+∞
6.9
7
*
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
+∞
6.9
7
*
N05AE04
ATC
ziprasidone; systemic
+∞
6.9
7
*
Q90.9
ICD-10 Finland
Down syndrome, unspecified
+∞
6.9
7
*
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
+∞
6.9
7
*
3460A
ICD-9 Finland
Migraine, Classical migraine
+∞
6.9
7
*
F21
ICD-10 Finland
Schizotypal disorder
+∞
6.9
7
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
+∞
6.9
7
*
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
+∞
6.9
7
*
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
+∞
6.9
7
*
F0022, G308
ICD-10 Finland
NA
+∞
6.9
7
*
29830
ICD-8 Finland
Other psychoses, Acute paranoid reaction
+∞
6.9
7
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
6.9
7
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
6.9
7
*
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
+∞
6.9
7
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
+∞
6.9
7
*
F0013, G301
ICD-10 Finland
NA
+∞
6.9
7
*
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
6.9
7
*
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
6.9
7
*
EBA00
NOMESCO Finland
Extraction of tooth
1.3
6.9
772
5579
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
8.7
6.8
14
14
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
8.7
6.8
14
14
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
7.0
6.8
16
20
AA1ED
NOMESCO Finland
Trauma CT of head and neck
7.7
6.8
15
17
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.2
6.8
65
259
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
6.8
288
1794
F40.1
ICD-10 Finland
Social phobias
11.6
6.8
12
9
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
2.2
6.7
67
271
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.8
6.7
21
38
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.6
6.7
144
1897
I67.2
ICD-10 Finland
Cerebral atherosclerosis
26.1
6.7
9
*
N06AA22
ATC
NA
6.2
6.7
17
24
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
6.7
284
1771
P04
ICPC
Feeling/behaving irritable/angry
13.7
6.7
11
7
M03BX02
ATC
tizanidine; oral
1.2
6.6
1441
11184
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
6.6
165
911
G04BD11
ATC
fesoterodine; oral
2.0
6.6
82
362
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.7
6.6
144
769
T89
ICPC
Diabetes insulin dependent
2.2
6.6
62
246
C08DB01
ATC
diltiazem; oral
1.7
6.6
132
690
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.5
6.6
22
43
315
Kela drug reimbursment
Clopidogrel
5.6
6.6
18
28
XCH00
NOMESCO Finland
Eye pressure measurement
0.5
6.6
38
711
62532
ICD-8 Finland
Other diseases of uterus, Endometriosis retro-cervicalis sive retrouterina
2.5
6.5
49
172
ZXA10
NOMESCO Finland
Bilateral
1.3
6.5
528
3656
D07AC01
ATC
betamethasone; topical
1.2
6.5
890
6573
H02BX01
ATC
methylprednisolone, combinations; systemic
1.7
6.5
133
696
H3600, E113
ICD-10 Finland
NA
3.0
6.5
35
102
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.4
6.5
32
636
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.5
6.5
36
684
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
6.5
77
336
L03AA02
ATC
filgrastim; parenteral
0.4
6.5
21
489
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.6
6.5
46
158
U29
ICPC
Urinary symptom/complaint other
2.0
6.5
79
349
R26
ICD-10 Finland
Abnormalities of gait and mobility
10.5
6.5
12
10
AA1BG
SPAT
NA
4.9
6.5
20
36
HA1RA
SPAT
NA
0.3
6.4
10
330
H53.2
ICD-10 Finland
Diplopia
2.2
6.4
60
236
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.8
6.4
25
57
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
6.4
396
2635
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
6.9
6.4
15
19
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
3.1
6.4
33
94
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
6.4
118
603
L60.0
ICD-10 Finland
Ingrowing nail
2.0
6.3
82
370
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
34.8
6.3
8
*
G43.3
ICD-10 Finland
Complicated migraine
34.8
6.3
8
*
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
34.8
6.3
8
*
IHZ08
SPAT
NA
34.8
6.3
8
*
G83.4
ICD-10 Finland
Cauda equina syndrome
34.8
6.3
8
*
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
34.8
6.3
8
*
G56.3
ICD-10 Finland
Lesion of radial nerve
12.0
6.3
11
8
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
2.9
6.3
36
107
N43
ICPC
Neurological, Other diagnostic procedure
4.7
6.3
20
37
C10AA02
ATC
lovastatin; oral
1.7
6.3
123
639
R95
ICPC
Chron obstructive pulmonary disease
2.1
6.3
69
293
A41.8
ICD-10 Finland
Other specified sepsis
2.4
6.2
48
173
V03AA01
ATC
NA
3.9
6.2
24
54
L03AA13
ATC
pegfilgrastim; parenteral
0.5
6.2
41
732
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
14.5
6.2
10
6
F41.3
ICD-10 Finland
Other mixed anxiety disorders
14.5
6.2
10
6
L11
ICPC
Wrist symptom/complaint
1.6
6.2
150
826
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.2
6.2
61
246
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
6.2
77
343
WX704
NOMESCO Finland
Intubation
1.6
6.2
162
907
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.6
6.2
143
775
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
19.6
6.2
9
*
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.7
6.2
25
59
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
6.1
305
1955
H3600, E103
ICD-10 Finland
NA
5.5
6.1
17
27
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
8.1
6.1
13
14
S16
ICPC
Bruise/contusion
2.0
6.1
77
346
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.1
1187
9085
C08CA07
ATC
nisoldipine; oral
3.1
6.1
31
87
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.0
6.1
33
97
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.8
6.1
107
538
J02AC01
ATC
fluconazole; systemic
1.2
6.1
834
6156
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
6.1
105
525
WZA90
NOMESCO Finland
Other doctors statement
1.3
6.1
527
3683
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
2.9
6.1
35
106
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.6
6.1
145
796
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.0
680
4907
G24.9
ICD-10 Finland
Dystonia, unspecified
61.1
6.0
7
*
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
61.1
6.0
7
*
G54.4
ICD-10 Finland
Lumbosacral root disorders, not elsewhere classified
61.1
6.0
7
*
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
61.1
6.0
7
*
F30.9
ICD-10 Finland
Manic episode, unspecified
61.1
6.0
7
*
Y94.1
ICD-10 Finland
Accident in connection with service housing
61.1
6.0
7
*
H3603, E113
ICD-10 Finland
NA
4.3
6.0
21
43
L76
ICPC
Fracture: other
2.1
6.0
67
286
N05BB01
ATC
hydroxyzine; systemic
1.7
6.0
115
593
N30
ICD-10 Finland
Cystitis
1.6
6.0
148
819
E66.9
ICD-10 Finland
Obesity, unspecified
2.5
6.0
43
149
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.9
6.0
84
393
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
588
235
17.90
307.65
1.2
1.1
mg/l
461.8
592.0
3.42
530
225
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
599
63
68.33
307.65
1.0
1.0
ng/l
535.5
845.2
6.94
431
51
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
599
63
68.33
307.65
1.0
1.0
ng/l
57.5
38.2
4.50
438
51
(3009466) Valproate [Moles/volume] in Serum or Plasma
308
15
142.30
307.65
3.2
1.5
umol/l
320.9
285.9
—
242
8
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
525
209
17.83
307.65
1.1
1.1
mmol/l
3.8
3.6
1.42
491
198
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
540
187
20.55
307.65
1.2
1.1
e6/l
12.0
51.4
0.67
419
134
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
592
63
67.47
307.65
1.0
1.0
ng/l
413.8
413.2
0.00
440
52
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
540
187
20.55
307.65
1.3
1.2
e6/l
254.6
440.4
0.30
428
147
(3044290) Cell count panel - Cerebral spinal fluid
458
197
16.37
307.65
1.2
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
3522
7956
4.40
307.65
2.0
1.7
nmol/l
1212.5
1130.5
4.49
2503
5674
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
4390
18272
2.28
272.67
2.5
1.9
pmol/l
90.5
92.4
1.73
2248
8985
(3023410) Appearance of Cerebral spinal fluid
262
78
23.12
268.96
1.3
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2795
9813
2.36
253.03
2.3
1.7
u/l
262.8
211.3
2.06
2564
8834
(3015377) Calcium [Moles/volume] in Serum or Plasma
3576
14185
2.20
239.68
2.6
3.8
mmol/l
2.4
2.4
1.91
2980
11947
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2433
8222
2.38
237.13
3.1
3.5
mmol/l
2.5
2.5
10.33
2097
7146
(3021960) Folate [Moles/volume] in Serum or Plasma
2819
10366
2.23
223.62
1.7
1.5
nmol/l
20.8
20.2
0.80
2461
8537
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2474
8784
2.25
211.12
1.8
1.7
pmol/l
447.2
31006152.2
5.99
1916
6831
(3026008) Bacteria identified in Urine by Culture
3344
13679
2.06
196.21
3.9
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
4167
18519
2.01
193.91
3.8
4.6
g/l
34.4
34.3
0.55
3687
16921
(3023368) Bacteria identified in Blood by Culture
3026
12057
2.06
188.73
4.1
4.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1969
6664
2.27
184.33
2.0
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
5465
27293
1.99
174.00
6.2
4.3
e6/l
3917.2
1254.6
2.02
149
412
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1476
4584
2.40
165.96
1.9
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3534
15521
1.91
159.98
4.7
3.4
ng/l
53.5
79.2
1.24
2819
11821
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1468
4620
2.36
159.76
1.9
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
204
116
12.01
159.10
1.2
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4215
19641
1.88
158.72
4.6
5.4
mmol/l
1.2
1.2
1.31
3674
17361
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4539
21810
1.86
153.12
5.3
6.2
mmol/l
1.2
1.2
9.07
3636
18125
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
848
2170
2.79
139.05
1.5
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
2940
12968
1.80
122.11
3.1
4.0
ph
7.4
7.4
1.60
502
2378
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3369
15486
1.76
121.51
2.1
2.1
nmol/l
77.8
81.8
9.67
2807
13241
(3013826) Glucose [Moles/volume] in Serum or Plasma
4651
23661
1.71
114.16
4.6
4.1
mmol/l
7.1
6.9
10.33
4363
22052
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2472
10950
1.72
95.90
2.3
2.2
mg/l
3.0
3.1
0.62
1971
9205
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3174
15096
1.65
93.92
2.5
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
447
1087
2.84
79.23
1.2
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1346
5244
1.85
78.25
1.7
1.9
s
29.7
30.5
4.01
1289
5100
(3019150) Specific gravity of Urine by Refractometry
1872
8127
1.69
74.89
5.5
4.0
kg/l
1.0
1.0
0.97
302
1290
(40768804) Tissue Pathology biopsy report
1805
17480
0.60
72.66
2.1
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
5071
28069
1.53
69.64
5.3
4.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
990
3719
1.88
63.43
2.5
2.2
ug/l
5.5
7.7
3.56
731
3231
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
109
98
7.51
63.06
1.4
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
801
2808
2.00
62.72
1.6
1.5
—
—
—
0
0
(3015736) pH of Urine
2978
14947
1.51
62.65
4.4
3.4
—
5.7
—
0
19
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
761
2622
2.03
62.47
1.9
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
539
1637
2.28
60.60
1.6
1.4
%
1.6
1.6
0.36
446
1313
(3022217) INR in Platelet poor plasma by Coagulation assay
1476
6377
1.66
58.25
30.4
29.2
inr
1.7
1.5
0.87
90
893
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4947
27763
1.47
57.77
3.7
3.8
pmol/l
15.2
15.2
0.10
4240
24084
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1030
10804
0.58
53.31
1.5
1.6
mmol/l
1.2
1.3
1.29
853
8675
(3035350) Ketones [Presence] in Urine by Test strip
3604
19225
1.44
53.06
4.7
3.6
estimate
0.0
0.0
0.00
576
3643
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
90
79
7.68
53.06
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
112
129
5.86
52.49
2.2
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
2166
10482
1.51
51.92
5.3
3.9
estimate
0.0
0.0
0.50
520
3451
(3032080) INR in Blood by Coagulation assay
3408
18154
1.43
49.34
11.1
10.2
inr
1.3
1.4
1.68
851
4884
(3008152) Bicarbonate [Moles/volume] in Arterial blood
697
2545
1.90
48.05
5.5
5.9
mmol/l
24.6
24.3
1.30
664
2348
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2803
14492
1.44
47.12
5.3
4.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1780
8438
1.52
46.12
4.3
3.5
ng/l
188.2
656.9
9.64
1603
7412
(3014271) Vancomycin [Susceptibility]
124
179
4.68
46.12
3.3
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
3615
19619
1.41
46.04
4.8
3.7
estimate
0.0
0.0
0.80
569
3609
(3023183) Ammonium ion [Moles/volume] in Plasma
231
526
2.99
45.80
1.5
1.9
umol/l
27.6
35.0
3.96
182
417
(40761535) Cells panel - Urine sediment
866
3443
1.76
45.35
4.0
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
3557
19396
1.39
43.04
6.1
4.9
estimate
0.0
0.0
0.00
559
3647
(3006653) Thiamine [Moles/volume] in Blood
64
47
9.15
42.83
1.1
1.1
nmol/l
132.3
137.1
0.17
64
47
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6441
38969
1.46
41.61
20.4
14.6
mg/l
31.9
29.1
6.55
5505
30648
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
359
1077
2.28
41.34
1.9
2.2
ug/l
1262.7
606.8
0.56
331
1029
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
85
95
6.02
41.02
1.1
1.1
mmol/l
2.0
2.2
0.72
78
85
(3019060) Gas panel - Arterial blood
698
2693
1.80
40.24
3.8
4.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2897
15430
1.39
39.20
4.2
3.6
e6/l
185.1
134.8
0.82
2092
10971
(3011397) Hemoglobin [Presence] in Urine by Test strip
1882
9282
1.46
39.15
4.7
3.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5879
35168
1.40
38.17
4.9
4.5
mu/l
2.0
2.2
2.96
5170
30453
(4035726)
351
4628
0.48
38.10
1.3
1.4
—
—
—
0
0
(4027681)
50
30
11.19
37.84
1.1
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2327
12014
1.41
37.38
2.2
2.4
u/l
59.2
62.7
1.30
2073
10904
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5140
38199
0.73
36.72
4.0
4.6
mmol/l
1.5
1.5
5.68
4341
33338
(3020191) Ethanol [Moles/volume] in Serum or Plasma
64
60
7.17
35.91
1.2
1.0
promille
0.8
0.8
0.07
51
47
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5140
38156
0.73
35.90
19.4
15.1
ml/min/173m2
68.9
70.1
3.68
4077
30894
(3003396) Base excess in Arterial blood by calculation
1086
4852
1.57
35.80
4.2
6.0
mmol/l
1.3
0.9
2.70
823
3770
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3515
19512
1.35
35.67
2.9
2.8
u/l
50.8
58.2
4.09
3017
17059
(3000850) Epithelial cells [#/volume] in Urine
1836
9184
1.43
34.78
2.8
2.6
e6/l
5.4
5.2
0.36
1599
7910
(36304419) Bacteria [Presence] in Urine
2266
11765
1.39
34.70
3.5
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2562
13597
1.37
34.25
3.6
3.2
e6/l
123.4
130.5
0.05
1991
10330
(1761868) Lipid panel - Serum or Plasma
1115
10541
0.66
33.91
3.2
3.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
62
61
6.83
33.47
1.1
1.1
mg/l
41.5
42.7
0.06
50
51
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1075
4872
1.54
33.09
4.3
6.0
kpa
5.0
5.0
1.81
1014
4607
(3027801) Oxygen [Partial pressure] in Arterial blood
1074
4869
1.54
33.01
4.3
6.0
kpa
11.4
12.2
4.45
1013
4605
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5244
38649
0.74
32.84
4.0
4.6
mmol/l
4.3
4.5
26.22
4458
34053
(3024354) Oxygen [Partial pressure] in Venous blood
783
3309
1.64
32.29
2.6
2.8
kpa
4.1
4.4
2.13
745
3202
(3026782) Osmolality of Urine
1751
8822
1.41
31.39
3.0
2.7
mosm/kgh2o
565.2
556.4
0.99
1462
7387
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2708
14691
1.34
30.57
2.7
2.7
ug/l
150.6
170.2
2.93
2294
13167
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4961
36649
0.76
29.30
3.6
4.1
mmol/l
1.2
1.2
0.39
4128
31586
(3003694) ABO and Rh group [Type] in Blood
1138
10463
0.68
29.27
1.3
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
135
296
3.08
28.63
1.2
1.2
nmol/l
316.6
315.1
0.02
108
217
(3016502) Oxygen saturation in Arterial blood
957
4375
1.52
28.02
4.4
6.2
%
94.9
95.4
1.16
919
4187
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
310
3859
0.52
27.78
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
210
593
2.40
27.73
1.1
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4852
28784
1.30
27.70
3.8
4.0
mm/h
15.9
15.5
0.88
4235
25654
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
55
59
6.26
27.61
1.0
1.1
mg/l
295.5
317.0
0.16
45
53
(3002256) Pathology report gross observation
622
6395
0.62
27.27
1.4
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
58
69
5.64
26.49
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1148
5507
1.45
26.41
10.2
6.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
885
4049
1.51
25.71
2.9
3.5
kpa
5.9
5.8
1.51
847
3936
(3043409) Potassium [Moles/volume] in Arterial blood
335
1182
1.93
25.36
3.5
3.7
mmol/l
3.9
3.9
0.34
302
1104
(3002032) Base excess in Venous blood by calculation
883
4053
1.51
25.24
2.9
3.5
mmol/l
2.1
1.8
1.05
725
3214
(3030467) Casts [#/volume] in Urine by Automated count
2313
12538
1.32
25.10
3.5
3.1
e6/l
0.6
0.5
0.31
1806
9318
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
943
4394
1.49
25.05
3.4
2.6
ng/l
229.8
264.4
1.58
866
4061
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
50
54
6.21
24.97
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
66
5.59
24.93
1.1
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5527
39967
0.77
24.75
4.7
5.2
mmol/l
2.5
2.6
31.93
4743
35050
(3002173) Hemoglobin [Mass/volume] in Arterial blood
876
4032
1.50
24.68
4.5
6.5
g/l
120.3
118.2
2.30
844
3873
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5316
32147
1.29
24.56
5.8
7.7
u/l
81.2
82.6
0.83
4808
29900
(3047181) Lactate [Moles/volume] in Blood
339
1220
1.89
24.20
4.5
4.8
mmol/l
1.5
1.3
1.13
310
1076
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
48
54
5.96
23.13
1.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
27
13
13.91
22.83
1.0
1.2
%
20.8
69.1
—
10
7
(3018405) Lactate [Moles/volume] in Arterial blood
370
1398
1.80
22.68
3.4
3.5
mmol/l
1.5
1.4
0.44
365
1366
(3020682) Albumin/Creatinine [Ratio] in Urine
1829
15046
0.76
22.16
3.3
3.8
mg/mmol
12.1
8.0
2.21
1099
9189
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
52
67
5.21
22.00
1.1
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3731
21774
1.26
21.89
4.1
6.5
umol/l
12.7
12.7
0.08
3380
20645
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
271
938
1.96
21.71
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
271
938
1.96
21.71
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
257
886
1.97
20.84
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
959
4637
1.43
20.83
4.8
3.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
598
2627
1.56
20.76
1.7
2.4
nmol/l
406.6
390.6
1.03
494
2411
(3018572) Chloride [Moles/volume] in Blood
257
888
1.96
20.71
4.6
5.4
mmol/l
104.5
104.8
0.34
238
787
(3039000) Anion gap in Blood
257
888
1.96
20.71
4.6
5.4
mmol/l
11.4
11.3
0.06
238
787
(3014765) Yersinia sp identified in Stool by Organism specific culture
258
897
1.95
20.43
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1715
14105
0.76
20.35
2.7
3.1
mg/l
521.8
292.7
1.08
1040
8596
(3020891) Body temperature
395
1571
1.71
20.32
4.0
4.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
258
901
1.94
20.17
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
24
12
13.39
19.91
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1725
14143
0.77
19.89
2.6
3.0
mmol/l
7.1
6.9
1.49
1310
11502
(3027945) Reticulocytes/100 erythrocytes in Blood
1134
5722
1.37
19.13
2.1
2.5
%
1.7
1.7
0.10
890
5066
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2620
14880
1.26
18.44
2.9
2.9
ng/l
2256.4
1819.6
3.39
2166
13033
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
496
4939
0.65
18.32
1.2
1.2
u/ml
17.8
20.3
0.20
118
1592
(3014111) Lactate [Moles/volume] in Serum or Plasma
779
3727
1.44
17.81
3.5
5.7
mmol/l
1.5
1.3
6.58
739
3581
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1453
7721
1.31
17.18
3.0
2.8
e6/l
1.7
1.6
0.05
831
4505
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1378
7270
1.32
17.16
3.2
2.9
e6/l
2.9
2.8
0.15
764
4075
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
468
2041
1.56
16.75
3.6
3.9
%
45.5
44.2
0.62
461
2015
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
27
817
0.22
16.68
1.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
466
2037
1.56
16.51
2.9
3.6
mmol/l
2.0
1.9
0.22
324
1456
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
71
1263
0.37
16.39
1.5
1.8
—
—
—
0
0
(3010421) pH of Blood
274
1047
1.77
16.25
3.8
3.8
ph
7.4
7.4
1.17
230
879
(3007853) Bacteria identified in Skin by Aerobe culture
851
4214
1.39
15.95
1.7
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
277
1068
1.76
15.94
1.2
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
429
1859
1.57
15.79
4.0
4.1
%
1.7
1.6
1.01
408
1745
(3003181) Sodium [Moles/volume] in Urine
195
674
1.95
15.79
1.3
1.3
mmol/l
63.0
60.6
0.38
153
546
(3009343) pH of Capillary blood
476
2117
1.53
15.61
2.9
3.6
ph
7.4
7.4
0.15
75
303
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
482
2154
1.52
15.47
2.9
3.7
kpa
5.2
5.1
2.56
416
1962
(3007930) Methemoglobin/Hemoglobin.total in Blood
421
1841
1.55
14.90
4.0
4.1
%
0.9
0.9
3.09
401
1724
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
44
71
4.15
14.58
1.2
1.4
umol/l
73.7
65.5
0.20
25
42
(3024891) Influenza virus A+B Ag [Presence] in Specimen
203
733
1.87
14.48
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
238
905
1.78
14.39
4.1
4.0
mmol/l
2.7
2.6
0.14
165
594
(3013290) Carbon dioxide [Partial pressure] in Blood
238
906
1.78
14.34
4.1
4.0
kpa
5.0
4.9
0.79
230
880
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
420
1852
1.54
14.33
1.8
1.8
ug/l
3.1
2.6
0.17
319
1640
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
432
1919
1.53
14.26
2.7
3.9
mmol/l
24.2
24.2
0.17
385
1734
(3025941) Bacteria identified in Stool by Culture
377
1625
1.57
14.21
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4992
30797
1.21
14.18
27.4
20.7
g/l
330.2
330.9
5.68
4875
30523
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
93
249
2.51
13.94
1.3
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
237
911
1.76
13.83
4.1
4.0
kpa
7.8
8.4
6.75
228
885
(3009542) Hematocrit [Volume Fraction] of Blood
5431
33811
1.21
13.82
22.8
17.0
%
36.8
37.9
7.95
2794
20366
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
569
5235
0.71
13.66
1.2
1.2
iu/ml
40.0
48.8
0.63
163
1618
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
91
244
2.51
13.61
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
319
3270
0.64
13.40
3.0
3.8
%
0.7
0.7
0.04
69
803
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
165
1990
0.54
13.21
3.0
4.6
u/ml
232.4
80.2
1.03
155
1924
(3021440) Promyelocytes/100 leukocytes in Blood
344
3447
0.65
12.98
3.0
3.9
%
0.2
0.1
1.01
97
1040
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
46
4.80
12.95
1.2
1.1
u/l
1.0
1.3
1.16
18
24
(3017181) Myelocytes/100 leukocytes in Blood
367
3620
0.66
12.82
3.0
3.9
%
1.2
0.9
0.53
107
1106
(3027273) Bicarbonate [Moles/volume] in Venous blood
478
2220
1.46
12.74
3.0
3.2
mmol/l
25.4
24.9
2.46
458
2163
(40757373) Influenza virus identified in Isolate
37
58
4.27
12.73
1.5
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
654
3221
1.39
12.60
2.8
3.6
ng/l
90.8
95.5
0.61
508
2667
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
28
5.97
12.16
1.1
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
421
1929
1.48
12.02
2.3
2.4
%
0.7
0.7
1.87
402
1853
(3004119) Hemoglobin [Mass/volume] in Venous blood
553
2668
1.41
12.01
2.7
3.0
g/l
127.9
125.7
1.53
541
2608
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
700
6093
0.75
11.71
2.8
4.4
ug/l
24.3
28.9
0.16
562
5135
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
757
3860
1.34
11.69
3.4
3.7
mmol/l
1.2
1.2
0.16
597
3270
(3008295) Osmolality of Serum or Plasma
105
324
2.18
11.57
1.4
1.3
mosm/kgh2o
277.0
275.5
0.18
69
245
(3040151) Glucose [Moles/volume] in Capillary blood
129
438
1.98
11.12
11.9
5.3
mmol/l
8.0
7.2
1.08
102
360
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1169
6362
1.26
11.06
2.3
3.0
mmol/l
0.8
0.8
0.03
1017
5848
(21494755) Public health laboratory ask at order entry panel
26
623
0.28
11.00
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
6324
40242
1.21
10.99
19.8
14.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
216
871
1.67
10.72
2.5
2.4
%
16.2
15.6
1.28
87
441
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
276
1186
1.57
10.63
3.2
4.1
mmol/l
25.0
24.6
1.05
230
1063
(40768800) Prostate Pathology biopsy report
115
1444
0.53
10.61
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
215
874
1.66
10.36
3.5
3.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
330
3188
0.68
10.35
3.0
3.9
%
0.1
0.5
1.83
82
855
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
26
36
4.83
10.32
1.2
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
26
36
4.83
10.32
1.2
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
26
36
4.83
10.32
1.2
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
344
1577
1.48
9.85
1.9
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
345
3272
0.69
9.80
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1732
9965
1.20
9.54
4.5
3.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
36
4.65
9.52
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
26
39
4.46
9.47
1.2
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
25
37
4.52
9.24
1.2
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1329
7473
1.22
9.24
1.6
1.6
mg/l
1.9
1.8
0.19
1003
5881
(40768793) Breast Pathology biopsy report
70
979
0.47
9.03
1.2
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
358
1683
1.44
9.03
2.2
2.4
au/ml
49.1
31.6
—
6
63
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
724
3818
1.29
8.77
1.6
2.1
g/l
0.2
0.2
0.96
606
3548
(3011288) Drugs identified in Urine by Screen method
19
23
5.52
8.63
1.4
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2455
18205
0.86
8.56
10.0
9.7
e9/l
0.0
0.0
0.16
1978
14699
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
360
1713
1.42
8.52
1.9
1.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
279
1270
1.48
8.33
3.7
3.0
nmol/l
0.8
0.8
0.35
211
989
(3022948) Iron [Moles/volume] in Serum or Plasma
1249
7048
1.22
8.32
2.1
2.4
umol/l
11.0
12.0
5.55
1071
6531
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
48
747
0.43
8.28
1.1
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
445
3937
0.74
8.27
1.2
1.3
titre
442.6
551.7
0.78
91
920
(3022313) Gas panel - Capillary blood
311
1452
1.45
8.17
3.0
3.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
517
4460
0.76
8.04
1.2
1.3
—
—
—
0
0
(4094501)
75
982
0.51
8.01
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
14
13
7.20
7.94
1.1
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1724
10065
1.18
7.87
3.5
3.7
%
80.5
83.7
5.22
1661
9861
(3016038) Potassium [Moles/volume] in Urine
79
258
2.05
7.70
1.1
1.1
mmol/l
36.6
38.0
0.18
63
216
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
13
12
7.24
7.40
1.1
1.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1010
5647
1.22
7.34
4.4
6.0
mmol/l
104.5
104.4
0.22
970
5530
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
104
1199
0.57
7.24
2.1
3.1
u/ml
310.9
809.2
1.28
88
1102
(3019550) Sodium [Moles/volume] in Serum or Plasma
6595
42534
1.17
7.22
24.6
17.6
mmol/l
139.7
139.6
1.94
6340
41134
(3000492) Spirometry study
286
2654
0.71
7.22
1.5
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
29
525
0.37
7.20
1.2
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
468
2395
1.32
7.10
3.9
6.2
mmol/l
24.8
24.7
0.23
460
2367
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
669
5502
0.80
7.07
4.3
4.7
%
34.4
33.5
1.02
363
3134
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
20
31
4.31
7.05
2.0
2.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
14
9
10.40
6.99
1.1
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
13
6.68
6.96
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
259
2428
0.70
6.95
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1316
10115
0.84
6.95
3.0
3.6
ug/l
0.9
0.9
0.01
945
7615
(3024869) Neuronal Ab [Presence] in Serum
15
18
5.57
6.88
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
6599
42605
1.17
6.86
24.6
17.8
mmol/l
4.0
4.0
0.08
6328
41131
(3004588) Protein electrophoresis panel - Serum or Plasma
602
3208
1.27
6.74
2.1
2.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
140
573
1.64
6.73
1.7
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
310
1503
1.39
6.67
1.2
1.3
au/ml
53.9
60.3
0.12
12
74
(40768443) Skin Pathology biopsy report
203
1959
0.68
6.43
1.1
1.2
—
—
—
0
0
(4281824)
34
544
0.41
6.39
1.3
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
19
31
4.10
6.33
2.2
2.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
217
2062
0.69
6.32
2.4
3.5
u/ml
204.3
2883.7
2.97
166
1775
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
98
1098
0.59
6.18
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
656
3575
1.24
6.08
2.1
2.3
u/l
32.7
59.2
0.75
526
3078
(4198724)
11
6
12.25
5.98
1.0
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
216
1007
1.44
5.83
2.7
3.1
mmol/l
25.1
24.7
0.74
192
874
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
376
0.34
5.78
1.9
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
26
57
3.05
5.78
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
526
2820
1.26
5.64
4.3
3.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
40
114
2.35
5.50
1.0
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
782
4393
1.21
5.41
2.3
2.7
e9/l
66.1
66.6
0.14
586
3321
(3016879) Cocaine [Presence] in Urine
25
57
2.93
5.24
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
31
80
2.59
5.22
1.5
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5717
39497
0.89
5.18
4.7
5.0
mmol/l
6.2
6.1
10.50
4836
34424
(3045142) Bone marrow Pathology biopsy report
46
605
0.50
5.14
1.3
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
937
5378
1.18
5.12
3.7
5.0
mmol/l
1.0
1.0
0.44
805
4902
(3051593) INR in Capillary blood by Coagulation assay
47
149
2.11
5.08
7.6
26.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
30
78
2.57
4.99
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
98
398
1.65
4.97
1.9
1.5
u/ml
31.0
23.7
0.66
23
69
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
501
2713
1.25
4.96
4.6
7.3
%
0.7
0.6
4.30
495
2688
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
35
99
2.37
4.92
1.1
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
64
2.72
4.80
1.1
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
37
110
2.25
4.68
1.6
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
37
110
2.25
4.68
1.7
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
710
4012
1.20
4.64
2.1
2.8
g/l
65.2
65.9
1.33
566
3615
(1002224) Polysomnography panel
78
305
1.71
4.58
1.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
26
66
2.63
4.55
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
26
66
2.63
4.55
1.1
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
641
3598
1.20
4.51
4.0
7.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
369
3081
0.79
4.50
1.3
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
196
945
1.39
4.49
2.3
2.1
g/l
128.5
124.6
1.45
164
669
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
82
881
0.62
4.47
1.1
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
46
574
0.53
4.40
2.3
2.3
u/ml
93.8
237.6
0.53
46
565
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
383
0.43
4.35
1.2
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
22
53
2.78
4.24
2.6
1.9
u/field
0.5
0.6
0.26
22
53
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
404
3315
0.80
4.23
2.9
2.8
ml/min/173m2
57.5
57.7
0.04
161
1445
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
761
4364
1.18
4.22
2.0
2.7
umol/l
10.5
11.5
0.44
616
3862
(40768441) Liver Pathology biopsy report
16
292
0.36
4.22
1.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
24
61
2.63
4.21
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
435
2373
1.24
4.08
5.1
7.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
246
0.32
4.04
2.5
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
25
67
2.50
3.98
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
55
203
1.81
3.96
2.0
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2721
19367
0.91
3.96
4.0
4.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
212
1060
1.34
3.93
1.3
1.4
ug/g
269.4
257.4
0.36
103
655
(3021901) Oxygen saturation in Capillary blood
164
787
1.40
3.91
2.6
2.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
42
518
0.54
3.91
3.0
3.6
%
56.8
58.3
0.10
24
304
(4034850)
226
1142
1.33
3.90
12.6
10.2
—
—
—
0
0
(3036489) Thrombin time
194
958
1.36
3.90
1.7
1.9
s
21.3
22.6
1.94
174
844
(4010399)
326
2712
0.79
3.89
1.4
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1116
6630
1.14
3.89
2.1
2.4
g/l
2.2
2.2
3.64
964
6131
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
128
1211
0.70
3.79
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
63
689
0.61
3.77
4.4
3.7
iu/ml
244.9
1758.2
—
9
105
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
485
0.53
3.75
1.7
1.5
g/l
0.9
0.9
0.05
30
341
(42870588) Differential panel, method unspecified - Blood
2186
13538
1.11
3.72
4.2
5.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
333
1785
1.26
3.69
2.6
3.4
pmol/l
4.3
4.4
0.85
271
1566
(3028026) IgM [Mass/volume] in Serum or Plasma
238
2041
0.77
3.67
1.8
1.9
g/l
1.7
1.5
0.31
186
1830
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
137
0.24
3.63
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
781
4546
1.16
3.62
4.3
4.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
174
857
1.36
3.59
1.6
2.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
520
0.56
3.57
1.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
620
3549
1.18
3.55
5.0
3.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
73
757
0.64
3.49
2.9
3.6
u/ml
34.9
47.4
0.59
66
734
(3027944) Amphetamines [Presence] in Urine
23
64
2.40
3.43
1.1
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
6634
43327
1.11
3.41
28.9
22.4
e9/l
7.2
6.8
13.73
6292
41292
(3030981) Hyaline casts [#/volume] in Urine by Automated count
447
2495
1.21
3.40
3.2
2.8
e6/l
0.5
0.3
0.58
439
2455
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
58
629
0.61
3.39
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
90
397
1.52
3.36
1.4
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
291
2407
0.80
3.35
2.0
1.9
nmol/l
10.3
10.7
0.30
233
2050
(3007461) Platelets [#/volume] in Blood
6630
43313
1.11
3.33
28.8
22.4
e9/l
237.6
239.4
1.31
6319
41461
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
87
382
1.53
3.33
2.7
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
45
517
0.58
3.32
1.6
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
6630
43317
1.11
3.30
28.7
22.3
pg
30.4
30.4
0.89
6399
42261
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
78
335
1.56
3.29
1.3
1.2
titre
314.2
570.0
0.44
12
21
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
41
147
1.87
3.29
1.7
2.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
6630
43321
1.11
3.28
28.9
22.4
e12/l
4.2
4.4
76.54
6290
41273
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
160
0.33
3.28
2.3
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
6
7.79
3.28
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
200
0.33
3.27
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
72
737
0.65
3.27
1.7
1.5
mg/l
1.9
3.6
1.76
55
542
(3000963) Hemoglobin [Mass/volume] in Blood
6630
43324
1.11
3.26
29.1
22.5
g/l
128.1
132.5
96.64
6387
42276
(3024731) MCV [Entitic volume]
6629
43318
1.11
3.26
28.8
22.3
fl
91.9
91.8
0.63
6400
42261
(3028626) Oxygen [Partial pressure] in Capillary blood
182
918
1.33
3.25
2.5
2.8
kpa
7.4
7.8
1.40
171
848
(1617658) Protocol used for examination of sentinel lymph nodes
27
357
0.50
3.21
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1785
11029
1.10
3.13
2.6
3.1
u/l
34.8
37.3
0.52
1624
10349
(40768797) Stomach Pathology biopsy report
702
5329
0.87
3.09
1.2
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
5457
37451
0.92
3.09
6.5
6.2
mmol/mol
42.2
40.4
25.18
4722
33157
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
199
1703
0.77
3.08
1.1
1.1
iu/ml
68.6
130.8
1.88
59
547
(3004809) Band form neutrophils/100 leukocytes in Blood
85
830
0.68
3.07
3.6
3.5
%
2.9
1.5
1.17
67
624
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
21
3.50
3.05
1.3
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
93
892
0.69
3.05
1.6
1.6
mg/l
13.5
12.0
0.85
73
810
(21494814) CD8 cells/100 lymphocytes in Specimen
7
144
0.32
3.02
5.1
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1038
6246
1.12
2.97
2.3
2.4
%
20.3
21.5
1.81
746
5364
(3033705) Calcium.ionized [Moles/volume] in Venous blood
137
672
1.37
2.97
2.8
2.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1482
10730
0.90
2.94
2.3
2.9
umol/l
10837.9
7435.4
1.14
1151
8975
(3042111) Morphology [Interpretation] in Bone marrow Narrative
102
953
0.71
2.90
1.4
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
29
97
2.00
2.86
1.0
1.1
nmol/l
2.8
3.8
—
5
14
(3021879) Hepatitis B virus core Ab [Presence] in Serum
209
1760
0.79
2.86
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
45
175
1.72
2.83
1.2
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
204
0.39
2.81
1.8
2.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
14
4.29
2.81
1.2
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
39
441
0.59
2.77
1.5
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
54
2.35
2.75
1.3
1.0
miu/ml
1565.7
1717.0
0.19
19
54
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
89
411
1.45
2.73
2.5
2.2
u/field
2.2
2.1
0.03
33
133
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
24
76
2.11
2.73
1.3
1.5
pmol/l
17.8
17.1
0.17
15
65
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
36
413
0.58
2.71
1.4
1.8
mg/l
4.4
4.5
0.04
30
383
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
23
3.20
2.70
1.3
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1019
6165
1.12
2.67
1.2
1.2
u/ml
2.0
2.3
0.26
210
1418
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
78
750
0.69
2.65
1.2
1.2
u/ml
4.6
5.4
0.15
12
115
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
12
4.45
2.62
1.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
180
1524
0.78
2.61
1.2
1.2
u/ml
307.6
237.7
0.56
159
1364
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
15
224
0.45
2.58
1.2
1.1
u/ml
0.3
1.5
—
5
81
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
78
746
0.70
2.58
1.2
1.2
u/ml
1.3
3.4
—
6
67
(21494434) Karyotype in Bone marrow
48
505
0.63
2.55
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
151
0.40
2.50
1.2
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
52
534
0.65
2.48
1.3
1.3
—
14.2
—
0
9
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
130
0.36
2.48
5.1
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
234
1268
1.24
2.47
3.1
3.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
122
0.33
2.47
1.0
1.4
—
1.6
—
0
17
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
302
1686
1.20
2.39
2.1
2.4
u/ml
0.4
0.3
1.67
175
888
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
78
364
1.43
2.32
1.4
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
25
302
0.55
2.32
3.6
1.8
e9/l
1.0
1.1
0.20
18
202
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
70
663
0.70
2.24
1.2
1.2
u/ml
1.1
8.1
—
6
44
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
55
543
0.67
2.21
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
812
5974
0.90
2.20
2.7
4.4
u/l
256.1
253.3
0.15
703
5661
(3026389) Candida sp identified in Specimen by Organism specific culture
92
448
1.37
2.18
1.3
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
10
162
0.41
2.16
1.3
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
3042
19465
1.07
2.14
4.7
5.5
e9/l
1.7
1.9
1.64
2537
16542
(40758292) HTLV I+II Ab panel - Serum
0
39
0.00
2.13
0.0
1.5
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
6
5.56
2.06
1.2
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
6
5.56
2.06
1.2
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
30
115
1.74
2.06
1.5
1.9
nmol/l
11.4
13.7
0.93
25
109
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
113
574
1.32
2.06
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
353
2725
0.86
2.04
1.4
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
109
552
1.32
2.03
5.4
5.6
mg/l
12.7
12.4
0.30
94
509
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
179
966
1.24
2.03
1.4
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
1634
10246
1.08
2.01
5.5
7.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
128
0.42
1.99
1.4
1.5
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
7
13
3.60
1.98
1.1
1.8
mmol/l
4.7
4.5
—
7
13
(3015171) Extractable nuclear Ab [Units/volume] in Serum
128
1086
0.78
1.97
1.2
1.2
u/ml
0.6
1.1
0.56
12
100
(3013115) Eosinophils [#/volume] in Blood
3065
19663
1.06
1.95
4.6
5.6
e9/l
0.2
0.2
0.84
2539
16652
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
37
0.00
1.93
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
10
4.01
1.91
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
10
4.01
1.91
1.2
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
36
374
0.64
1.89
1.3
1.3
u/l
14.4
13.1
0.17
27
300
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
197
0.51
1.88
1.0
1.0
u/ml
2.5
2.0
—
5
89
(3036603) Volume of Urine
26
291
0.60
1.88
2.8
1.6
ml
1537.7
1853.5
0.99
12
83
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
160
1313
0.81
1.86
1.5
1.6
u/l
38.2
38.4
0.02
119
1100
(40760892) CBC W Ordered Manual Differential panel - Blood
1035
7453
0.92
1.83
3.8
4.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
62
576
0.72
1.83
1.2
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
304
0.61
1.80
1.3
1.4
g/l
0.5
0.4
0.20
19
198
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
304
0.61
1.80
1.3
1.4
g/l
6.9
7.4
0.22
19
198
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
304
0.61
1.80
1.3
1.4
g/l
2.6
2.9
0.38
19
198
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
41
178
1.54
1.79
1.1
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
41
178
1.54
1.79
1.1
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
96
832
0.77
1.78
2.7
2.2
%
204.0
216.8
0.76
88
778
(3001604) Monocytes [#/volume] in Blood
2961
19018
1.06
1.78
4.5
5.4
e9/l
0.6
0.6
0.27
2454
15821
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
107
914
0.78
1.78
1.5
1.4
g/l
1.1
1.2
0.47
98
854
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
11
3.64
1.78
1.3
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
33
0.00
1.76
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
46
446
0.69
1.75
1.1
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
218
1222
1.20
1.74
3.6
3.2
mmol/l
1.7
1.6
0.74
212
1197
(44813793)
13
174
0.50
1.74
1.0
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
120
1008
0.79
1.74
1.9
2.1
g/l
3.6
3.8
0.65
114
956
(4062490)
28
301
0.62
1.74
1.4
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
90
783
0.76
1.73
1.2
1.2
u/ml
3.6
49.8
—
5
46
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
8
4.17
1.71
1.0
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
329
2512
0.87
1.69
2.6
2.9
g/l
10.6
10.8
0.26
271
2309
(3017704) Immunofixation for Urine
59
280
1.41
1.69
1.4
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2976
19147
1.06
1.67
4.5
5.4
e9/l
0.0
0.0
2.09
2472
15931
(3020961) Endomysium IgA Ab [Titer] in Serum
209
1174
1.19
1.65
1.1
1.1
titre
440.7
270.4
—
7
27
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
239
0.59
1.65
3.0
1.7
%
14.2
16.1
0.27
12
88
(3045424) Erythrocytes [Presence] in Urine
68
610
0.74
1.64
1.4
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
20
2.67
1.64
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
52
243
1.43
1.63
2.4
2.3
ph
7.4
7.4
0.43
12
106
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
51
478
0.71
1.62
1.3
1.3
u/ml
112.0
131.5
0.51
13
103
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
45
429
0.70
1.59
1.2
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
29
0.00
1.57
0.0
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
926
5735
1.09
1.57
1.9
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
36
357
0.67
1.57
1.2
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
99
0.40
1.55
6.0
9.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
51
473
0.72
1.54
1.1
1.1
iu/ml
100.3
729.5
—
10
64
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
393
2332
1.13
1.53
4.5
7.6
mmol/l
24.2
24.3
0.16
347
2159
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
37
2.17
1.52
1.3
1.7
umol/l
43.8
45.5
0.07
12
37
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
107
893
0.80
1.51
1.5
1.4
g/l
0.2
0.2
0.09
97
835
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
232
0.60
1.50
3.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
62
554
0.75
1.49
1.1
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
92
479
1.29
1.49
1.3
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
22
86
1.71
1.47
1.3
1.6
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
29
123
1.58
1.44
1.0
1.5
%
84.1
58.8
7.61
18
111
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
254
0.63
1.44
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
254
0.63
1.44
1.3
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
51
244
1.40
1.44
2.3
1.8
u/field
1.9
3.3
0.90
34
152
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
72
626
0.77
1.43
1.2
1.3
u/l
349.6
434.8
0.40
65
605
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
108
578
1.25
1.41
2.1
1.9
mg/l
37.0
27.1
0.63
27
119
(3020779) Urea [Moles/volume] in Serum or Plasma
652
3998
1.10
1.41
4.2
5.7
mmol/l
11.6
11.6
0.03
590
3744
(3042631) Mycobacterium sp identified in Specimen
84
713
0.78
1.39
2.4
2.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
43
401
0.71
1.37
1.1
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
337
0.69
1.35
1.3
1.2
mmol/l
7.0
8.3
1.76
26
210
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
92
487
1.26
1.33
1.4
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
373
2229
1.12
1.33
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1459
10245
0.94
1.33
2.3
2.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
69
596
0.77
1.33
1.2
1.4
mmol/l
6.6
6.2
0.51
59
552
(44806118)
76
394
1.29
1.30
1.4
1.3
—
—
—
0
0
(44790048)
76
394
1.29
1.30
1.4
1.3
—
—
—
0
0
(44790049)
76
394
1.29
1.30
1.4
1.3
—
—
—
0
0
(44790047)
76
394
1.29
1.30
1.4
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
46
419
0.73
1.29
1.1
1.2
u/ml
272.3
260.4
0.11
35
254
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
79
0.42
1.29
5.4
1.8
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
23
2.32
1.27
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
23
2.32
1.27
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
23
2.32
1.27
1.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
163
922
1.18
1.26
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
345
2568
0.89
1.26
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
86
717
0.80
1.25
1.4
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
107
871
0.82
1.25
1.6
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
48
234
1.37
1.25
3.3
4.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
162
0.58
1.23
1.1
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
162
0.58
1.23
1.1
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
193
1110
1.16
1.23
1.4
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
11
136
0.54
1.22
1.7
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
253
1486
1.14
1.21
1.9
2.2
g/l
36.6
36.7
0.12
176
1246
(40758358) Immune stain study
0
23
0.00
1.20
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
42
202
1.39
1.19
1.3
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
24
0.00
1.19
0.0
2.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
32
2.09
1.19
1.4
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
24
241
0.66
1.18
1.2
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
118
654
1.21
1.16
1.3
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
29
279
0.69
1.15
3.1
3.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
115
920
0.83
1.15
1.3
1.5
g/l
29.5
32.2
1.71
102
822
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
166
1286
0.86
1.13
1.6
1.6
titre
112.3
261.0
1.62
13
77
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
51
446
0.76
1.12
1.1
1.2
u/l
59.1
70.1
0.59
27
302
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
272
1616
1.13
1.12
2.0
2.4
g/l
1.2
1.3
0.10
193
1359
(3007164) IgA [Mass/volume] in Serum or Plasma
791
5630
0.93
1.11
1.5
1.5
g/l
2.7
2.7
0.03
367
3016
(3051387) C reactive protein [Mass/volume] in Capillary blood
180
1040
1.16
1.11
4.5
3.2
mg/l
38.4
30.0
1.71
135
667
(3044889) 12 lead EKG panel
4538
29715
1.04
1.10
4.8
4.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
95
769
0.82
1.08
1.1
1.2
titre
80.0
150.6
—
6
62
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
148
844
1.17
1.08
1.5
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
21
2.23
1.08
1.1
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
23
228
0.67
1.08
1.0
1.1
u/l
45.0
25.8
0.57
15
162
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
101
0.53
1.06
1.0
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
23
227
0.68
1.06
1.0
1.1
u/l
98.5
85.7
0.30
17
172
(3012441) Differential panel - Pleural fluid
88
715
0.82
1.05
1.4
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
113
896
0.84
1.04
1.8
2.0
%
90.9
86.0
1.87
103
838
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
27
123
1.47
1.04
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
422
2580
1.10
1.04
2.5
2.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
59
500
0.79
1.03
4.5
3.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
230
1728
0.89
1.03
2.2
1.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
39
1.88
1.03
1.1
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
19
80
1.59
1.03
1.3
1.3
%
23.0
27.0
0.21
13
58
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
153
0.61
1.02
1.8
1.4
e6/l
1697.8
17622.8
—
8
90
(3027923) C peptide [Moles/volume] in Serum or Plasma
29
135
1.44
1.01
1.1
1.3
nmol/l
1.3
1.2
0.20
17
111
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
20
0.00
1.01
0.0
3.1
—
—
—
0
0
(4015189)
9
109
0.55
1.01
1.9
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
22
216
0.68
1.00
1.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
32
1.88
0.99
1.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
400
2446
1.10
0.99
1.5
1.7
g/l
1.6
1.6
0.10
302
2082
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
262
0.71
0.98
1.0
1.1
u/ml
1.0
4.5
—
7
52
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
35
1.91
0.97
1.4
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
81
0.49
0.96
3.8
2.9
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
23
222
0.69
0.96
1.1
1.1
mmol/l
13.2
12.1
—
7
72
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6263
42245
0.96
0.94
9.8
10.7
u/l
22.9
23.6
0.82
5813
39933
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
123
957
0.86
0.93
1.5
1.5
iu/ml
37.7
5.3
0.55
41
249
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
165
0.65
0.93
1.2
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
51
430
0.79
0.89
1.1
1.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
40
203
1.32
0.87
1.8
2.0
umol/l
19.1
47.7
—
5
14
(3035637) Corticotropin [Mass/volume] in Plasma
48
406
0.79
0.87
1.1
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
19
84
1.51
0.86
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
101
792
0.85
0.86
1.2
1.3
u/l
55.7
45.0
0.26
85
670
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
64
523
0.82
0.85
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
47
1.71
0.85
1.1
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2660
17306
1.04
0.85
4.7
6.1
ug/l
4.5
4.6
0.05
2211
15289
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
8
95
0.56
0.85
1.0
1.0
—
1.6
—
0
10
(3048879) Bone marrow aspiration report
18
177
0.68
0.85
1.1
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
129
0.62
0.85
2.0
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
246
1484
1.11
0.84
2.3
3.1
g/l
0.3
0.3
0.20
82
656
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
8
30
1.78
0.83
1.0
1.1
umol/24h
1.7
1.5
—
8
30
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
54
447
0.81
0.82
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
372
2686
0.92
0.81
4.4
3.6
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
17
0.00
0.81
0.0
1.6
—
356.4
—
0
17
(44806420)
23
214
0.72
0.81
2.0
2.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
167
0.68
0.81
1.8
1.6
e6/l
552.2
1406.7
—
10
113
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
18
0.00
0.81
0.0
16.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
11
119
0.62
0.81
7.0
5.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
31
1.72
0.81
1.3
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
29
259
0.75
0.80
1.1
1.3
titre
80.0
144.7
—
5
45
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
29
258
0.75
0.78
2.0
2.4
ug/min
31.7
115.5
—
6
55
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
77
611
0.84
0.78
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
34
1.77
0.78
2.0
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
34
1.77
0.78
1.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
43
225
1.28
0.77
1.0
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
15
2.23
0.77
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
24
219
0.73
0.77
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
90
0.59
0.75
4.6
2.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
80
630
0.85
0.75
1.4
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
216
1304
1.11
0.75
2.0
2.3
g/l
0.0
0.0
0.50
168
1183
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
92
0.58
0.75
1.1
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
63
506
0.83
0.74
1.1
1.3
u/l
30.7
12.5
1.14
53
476
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
155
0.69
0.72
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
57
461
0.82
0.72
1.3
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
131
0.66
0.72
1.2
1.8
ug/l
7.5
12.2
0.94
13
118
(3013650) Neutrophils [#/volume] in Blood by Automated count
3492
22887
1.03
0.71
6.4
9.1
e9/l
4.7
4.3
14.79
2966
19580
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
24
216
0.74
0.71
1.1
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
24
216
0.74
0.71
1.1
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
24
216
0.74
0.71
1.1
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
96
0.63
0.71
5.6
1.5
%
206.1
189.4
—
9
87
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
12
50
1.60
0.71
2.8
5.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
227
1380
1.10
0.70
2.0
2.2
g/l
0.0
0.1
0.54
178
1254
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
22
200
0.73
0.70
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
22
200
0.73
0.70
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
22
200
0.73
0.70
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
114
0.64
0.69
1.3
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
62
0.54
0.69
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
61
487
0.83
0.68
1.2
1.2
u/ml
77.8
44.0
—
6
48
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
199
0.74
0.68
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
22
199
0.74
0.68
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
199
0.74
0.68
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
231
1686
0.91
0.68
2.7
2.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
214
0.75
0.68
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
24
214
0.75
0.68
1.2
1.4
%
1.6
1.7
0.02
17
171
(3034092) Cytoplasmic Ig cells/100 cells in Blood
10
40
1.67
0.68
10.9
9.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
55
443
0.83
0.68
1.1
1.5
mu/l
31.5
59.8
1.19
44
399
(3034891) Synovial lining cells/100 cells in Synovial fluid
23
206
0.74
0.67
1.0
1.5
%
3.3
4.4
—
7
53
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
113
0.65
0.67
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
285
1756
1.09
0.67
2.2
2.3
g/l
3.2
3.2
0.17
184
1366
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
309
1911
1.08
0.66
2.1
2.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
26
228
0.76
0.66
5.5
6.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
309
1912
1.08
0.66
2.1
2.2
g/l
7.6
7.7
0.09
189
1409
(3020491) Glucose [Moles/volume] in Blood
48
261
1.23
0.66
2.1
2.6
mmol/l
6.9
7.3
0.76
35
181
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
31
265
0.78
0.66
1.6
1.5
u/l
5.2
6.9
0.29
12
131
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
308
1906
1.08
0.65
2.1
2.2
g/l
4.0
3.8
0.39
182
1337
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
17
159
0.71
0.65
1.0
1.0
mg/l
273.5
300.4
0.72
12
140
(40768446) Kidney Pathology biopsy report
10
104
0.64
0.65
1.0
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
67
527
0.85
0.65
1.9
2.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
33
279
0.79
0.64
1.2
1.9
%
10.0
10.7
0.37
33
279
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
34
178
1.28
0.64
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
69
0.58
0.64
1.0
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
106
804
0.88
0.64
1.3
1.5
e6/l
4881.0
1705.5
0.93
77
550
(3028308) Erythrocytes [#/volume] in Pleural fluid
97
740
0.87
0.63
1.3
1.5
e6/l
54863.9
42434.9
0.26
58
412
(3012565) Volume of 24 hour Urine
23
203
0.76
0.62
1.6
2.1
ml
1594.3
1813.2
0.36
14
167
(3019069) Monocytes/100 leukocytes in Blood
2782
18205
1.03
0.62
5.0
6.0
%
8.9
9.0
0.40
2495
16740
(3019174) dRVVT (LA screen)
0
14
0.00
0.62
0.0
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2827
18507
1.03
0.61
5.0
5.9
%
23.7
25.9
17.82
2516
16897
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
15
0.00
0.61
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
34
1.57
0.60
1.1
1.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
150
1.29
0.60
1.1
2.2
mg/l
62.0
73.8
0.39
17
109
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
179
0.75
0.60
1.1
1.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
23
1.74
0.58
1.2
1.1
u/l
13.3
10.9
—
6
23
(3021387) Prolactin [Units/volume] in Serum or Plasma
53
296
1.20
0.58
2.0
1.8
mu/l
253.3
303.9
0.90
48
282
(3014051) Protein [Presence] in Urine by Test strip
133
987
0.90
0.58
2.6
2.2
—
—
—
0
0
(4133840)
5
59
0.57
0.57
1.6
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
90
684
0.88
0.57
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
597
4178
0.95
0.57
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
54
303
1.19
0.57
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
177
0.75
0.56
1.1
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
49
390
0.84
0.56
1.2
1.3
nmol/l
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
83
0.64
0.56
1.1
1.4
ng/l
111.3
134.8
—
8
83
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
30
158
1.27
0.56
1.1
1.1
—
—
—
0
0
(3013512) EKG study
2016
13763
0.97
0.55
4.5
4.1
—
—
—
0
0
(44806071)
6
25
1.60
0.55
1.3
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
52
410
0.85
0.54
1.1
1.4
pmol/l
238.6
267.2
0.43
38
325
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
88
1.37
0.54
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
88
1.37
0.54
1.6
1.9
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
99
0.67
0.54
3.3
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
2763
18118
1.03
0.53
4.7
5.7
%
2.8
2.8
0.62
2476
16597
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
21
182
0.77
0.52
2.2
2.7
%
41.3
33.3
—
7
64
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
288
1799
1.07
0.52
2.0
2.3
g/l
10.5
10.5
0.06
204
1496
(3051611) Lipemic interference index of Serum or Plasma
83
487
1.14
0.52
3.0
3.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
159
0.76
0.51
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
159
0.76
0.51
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
57
443
0.86
0.51
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
504
3208
1.05
0.50
1.8
2.0
ug/g
165.8
158.0
0.17
353
2425
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
97
724
0.89
0.49
2.6
2.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
18
157
0.76
0.48
2.2
1.8
u/ml
876.4
1727.7
1.87
18
157
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
26
216
0.80
0.47
1.1
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
39
217
1.20
0.47
1.3
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
65
496
0.87
0.47
3.1
3.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
208
1290
1.08
0.47
2.1
2.3
g/l
0.0
0.0
0.00
169
1182
(3022096) Basophils/100 leukocytes in Blood
2687
17642
1.02
0.47
4.7
5.7
%
0.6
0.7
4.04
2407
16193
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
171
0.78
0.46
1.1
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
33
1.42
0.45
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
51
1.44
0.44
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
66
500
0.88
0.44
1.2
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
67
507
0.88
0.44
1.4
1.5
%
73.5
62.7
2.00
46
322
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
102
0.72
0.44
1.8
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
13
117
0.74
0.43
29.2
27.3
ug/l
93.8
111.1
0.69
13
102
(3024522) Salmonella sp identified in Specimen by Organism specific culture
67
506
0.88
0.43
1.2
1.3
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
10
0.00
0.42
0.0
6.0
—
454.7
—
0
10
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
10
0.00
0.42
0.0
9.4
—
204.5
—
0
10
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
10
0.00
0.42
0.0
9.9
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
10
0.00
0.42
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
66
498
0.88
0.42
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
66
498
0.88
0.42
1.2
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
14
69
1.35
0.42
1.1
1.1
umol/24h
0.7
0.7
—
8
30
(3000012) Reticulocyte production index
55
320
1.15
0.41
1.7
1.6
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
12
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.41
0.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.41
0.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
119
726
1.10
0.41
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
66
497
0.89
0.41
1.2
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
145
0.78
0.40
1.3
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
132
811
1.09
0.40
1.5
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
73
544
0.89
0.39
1.9
2.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
9
44
1.37
0.39
1.3
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
37
289
0.85
0.39
1.5
1.7
pmol/l
168.0
204.4
2.05
32
266
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
94
1.28
0.38
1.1
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
88
648
0.91
0.38
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
310
0.86
0.38
1.4
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
27
149
1.21
0.37
2.1
2.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
31
245
0.84
0.37
1.2
1.2
u/l
85.2
95.9
0.18
24
215
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
31
245
0.84
0.37
1.1
1.5
%
65.6
66.8
0.06
22
198
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
69
514
0.90
0.37
1.2
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1991
13513
0.98
0.36
2.4
2.5
—
—
—
0
0
(3001729) Color of Synovial fluid
9
47
1.28
0.36
1.0
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
77
569
0.90
0.36
1.3
1.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
53
0.63
0.36
1.0
2.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
38
294
0.86
0.36
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
83
0.72
0.36
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4837
32037
1.02
0.35
24.7
19.0
%
14.0
13.9
5.50
4693
31122
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
40
307
0.87
0.35
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
44
335
0.88
0.34
1.1
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
6
58
0.69
0.34
2.8
1.6
pmol/l
69.0
40.1
—
6
47
(3018010) Neutrophils/100 leukocytes in Blood
2756
18174
1.02
0.32
4.8
5.7
%
60.9
58.7
14.94
2469
16687
(3045716) Anion gap in Serum or Plasma
32
183
1.17
0.32
1.5
2.0
mmol/l
8.6
9.0
0.25
23
137
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
56
334
1.12
0.32
1.0
1.1
—
17.0
—
0
11
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
131
815
1.07
0.32
1.3
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
13
67
1.30
0.31
1.2
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
68
0.69
0.31
1.4
1.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
55
409
0.90
0.31
2.4
2.9
mg/l
30.5
24.5
0.20
33
292
(3000475) Leukocytes [#/volume] in Synovial fluid
157
985
1.07
0.31
1.5
1.6
e6/l
23768.4
12693.8
0.85
108
692
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
88
0.76
0.30
1.1
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
49
291
1.12
0.30
1.2
1.2
nmol/l
1.1
1.4
2.46
43
262
(46235355) HIV 1 and 2 tests - Meaningful Use set
439
2829
1.04
0.30
1.4
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
48
285
1.12
0.30
1.2
1.2
miu/ml
259.4
179.6
—
7
71
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
189
0.85
0.29
1.2
1.3
ug/l
878.0
131.6
0.47
17
99
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
72
0.74
0.29
1.1
1.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
8
73
0.73
0.29
5.1
1.6
%
200.6
209.6
—
8
63
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
37
281
0.88
0.29
1.0
1.1
%
116.2
115.5
0.06
28
233
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
94
581
1.08
0.28
1.1
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
38
287
0.88
0.28
2.3
2.0
min
512.1
498.6
0.54
25
209
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
200
1269
1.05
0.28
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
39
294
0.88
0.28
2.9
2.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
81
0.74
0.28
1.3
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
43
1.24
0.27
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
57
345
1.10
0.27
1.2
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
176
1115
1.05
0.27
2.1
2.4
ug/min
106.0
101.1
0.06
90
628
(3000285) Sodium [Moles/volume] in Blood
14
75
1.25
0.26
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
69
1.26
0.26
1.1
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
28
162
1.15
0.26
4.2
3.4
%
53.7
54.0
0.03
28
154
(40762814) Titanium [Mass/volume] in Blood
17
94
1.21
0.25
2.1
2.2
ug/l
2.8
3.8
—
10
37
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
44
264
1.11
0.25
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
55
0.73
0.24
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
128
0.83
0.24
2.8
2.2
—
—
—
0
0
(4268621)
26
199
0.87
0.24
2.0
2.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
32
241
0.89
0.24
1.2
1.2
u/l
27.2
28.7
0.05
23
206
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
60
436
0.92
0.24
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
37
276
0.89
0.24
4.4
5.7
u/ml
16.1
118.5
—
6
76
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
24
139
1.15
0.22
1.3
1.3
%
25.0
19.5
0.40
17
118
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
98
0.82
0.22
1.1
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
205
1313
1.04
0.22
3.1
3.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
161
1126
0.95
0.22
1.2
1.4
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
7
0.00
0.22
0.0
3.3
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
7
0.00
0.22
0.0
1.0
—
8.7
—
0
7
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.22
0.0
2.7
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
7
0.00
0.22
0.0
1.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
71
1.22
0.21
1.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
350
0.91
0.21
1.2
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
350
0.91
0.21
1.2
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
350
0.91
0.21
1.2
1.4
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
9
0.00
0.21
0.0
1.0
—
8.2
—
0
9
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
31
1.29
0.21
1.7
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
61
377
1.08
0.20
1.1
1.5
e6/l
138117.2
109546.9
0.10
38
272
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
32
1.25
0.20
1.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
264
1704
1.04
0.20
2.9
3.4
ratio
2.6
4.3
0.49
17
131
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
14
111
0.84
0.20
1.3
1.2
u/l
62.0
34.9
—
8
99
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
82
582
0.94
0.19
1.4
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
82
0.81
0.19
1.0
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
38
1.23
0.18
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
161
1119
0.96
0.18
1.9
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
42
257
1.09
0.18
1.1
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
56
401
0.93
0.17
1.3
1.5
%
14.5
29.4
4.83
37
254
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
44
0.76
0.17
1.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
45
1.19
0.17
1.0
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
16
92
1.16
0.17
1.5
1.6
ug/l
0.4
0.4
—
6
54
(3017569) Oxygen content in Arterial blood
34
207
1.10
0.16
2.8
2.3
—
—
—
0
0
(4146454)
71
502
0.94
0.16
2.6
2.6
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
29
213
0.91
0.16
1.0
1.1
%
96.2
92.6
0.37
22
190
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
53
0.76
0.16
1.5
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
22
131
1.12
0.15
1.1
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
14
108
0.87
0.15
1.0
1.1
mmol/l
1.5
1.7
—
7
67
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
54
1.11
0.15
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2099
13904
1.01
0.14
4.4
5.1
%
21.4
22.3
1.98
1025
8131
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
142
982
0.96
0.14
2.4
2.6
mg/l
1.7
1.7
0.01
110
861
(3034426) Prothrombin time (PT)
8
65
0.82
0.14
1.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
114
0.88
0.14
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
43
307
0.93
0.13
1.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
97
621
1.04
0.13
1.3
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
74
0.81
0.13
1.1
1.1
—
—
—
0
0
(4306422)
40
286
0.93
0.13
1.2
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
23
139
1.10
0.13
1.7
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
152
1.10
0.13
1.0
1.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
15
88
1.14
0.12
1.2
1.3
%
12.7
23.5
—
8
67
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
173
1188
0.97
0.12
2.0
1.8
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
30
185
1.08
0.12
1.2
1.3
mmol/l
4.4
3.0
1.29
23
172
(4212803)
11
63
1.17
0.12
1.2
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
126
0.90
0.11
1.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
61
427
0.95
0.11
2.2
2.2
ml
676.2
671.3
0.03
30
274
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
15
89
1.13
0.11
3.0
2.3
mmol/l
7.9
7.5
—
9
56
(3049717) Cytology report of Urine Cyto stain
340
2231
1.02
0.10
2.5
3.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
77
0.87
0.10
1.6
2.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
83
1.13
0.10
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
112
771
0.97
0.10
1.5
1.6
iu/l
3.2
5.2
2.14
33
240
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
30
1.11
0.10
1.2
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
31
1.08
0.09
1.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
46
323
0.95
0.09
1.4
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
25
155
1.08
0.09
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
21
129
1.09
0.09
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
52
363
0.96
0.09
1.1
1.1
u/ml
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
102
701
0.97
0.08
1.2
1.3
nmol/l
0.9
0.7
0.85
79
586
(3044007) Cell count panel - Peritoneal fluid
18
131
0.92
0.08
1.9
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
268
1761
1.02
0.08
2.9
3.4
mg/l
51.2
51.3
0.00
203
1442
(3013293) Extractable nuclear Ab [Presence] in Serum
6
50
0.80
0.07
1.3
1.6
—
—
—
0
0
(4024509)
56
387
0.97
0.06
1.3
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
107
698
1.02
0.06
1.4
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
50
346
0.96
0.06
1.8
1.9
ug/l
2.3
3.7
0.93
45
308
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
52
335
1.04
0.06
1.2
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
111
757
0.98
0.06
1.5
1.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
13
79
1.10
0.06
1.0
1.1
mmol/l
1.2
1.4
—
6
53
(1761482) Bacteria [#/volume] in Urine by Culture
245
1615
1.01
0.06
5.1
4.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
62
426
0.97
0.05
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
91
621
0.98
0.05
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
37
257
0.96
0.05
1.9
1.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
60
1.11
0.05
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
43
297
0.97
0.05
1.0
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
267
1765
1.01
0.04
2.9
3.4
mg/l
51.7
94.8
0.73
199
1439
(4211845)
35
225
1.04
0.04
5.0
3.8
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
11
67
1.10
0.04
1.0
1.1
u/l
43.2
55.5
—
5
46
(3035880) pH of Pleural fluid
52
355
0.98
0.03
1.1
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
193
1277
1.01
0.03
1.6
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
15
106
0.94
0.03
1.1
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
51
333
1.02
0.03
1.8
2.0
ug/l
1.6
2.1
0.85
42
287
(3034274) Bile acid [Moles/volume] in Serum --fasting
19
121
1.05
0.02
1.1
1.3
umol/l
5.7
14.7
0.65
12
78
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
13
82
1.06
0.01
1.8
1.4
ug/l
9.6
9.2
0.16
13
82
(3017732) Neutrophils [#/volume] in Blood
352
2357
1.00
0.01
3.3
3.0
e9/l
4.5
4.3
0.34
211
1628
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
69
466
0.99
0.01
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
45
305
0.98
0.01
1.1
1.1
u/ml
6.0
3.8
0.38
16
125
(3006442) Creatine [Moles/volume] in Serum or Plasma
30
203
0.99
0.00
2.6
1.7
—
72.8
—
0
6
(3006462) Nitrate [Presence] in Urine
32
210
1.02
0.00
5.1
3.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
38
255
0.99
0.00
1.3
1.4
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
16
105
1.02
0.00
1.3
1.2
g/l
28.2
30.2
0.21
11
89
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
101
0.99
0.00
1.4
1.4
u/l
3.2
503.3
—
5
40
(3014148) Varicella zoster virus Ab [Titer] in Serum
24
163
0.98
0.00
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
62
417
0.99
0.00
1.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
38
256
0.99
0.00
1.3
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
48
323
0.99
0.00
1.1
1.2
u/ml
1.6
4.8
0.84
12
104
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
36
237
1.01
0.00
2.9
3.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
23
154
1.00
0.00
1.1
1.2
g/l
41.6
39.0
0.62
13
79
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
7
47
0.99
0.00
1.7
1.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
39
0.86
0.00
2.0
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
3.4
—
0
5
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
35
0.95
0.00
1.0
1.5
%
100.4
104.7
—
5
35
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
36
0.93
0.00
1.0
1.4
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.8
—
0
6
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: G6_ALZHEIMER_EXMORE – Alzheimer disease, excluding more controls
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).